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ABSTRACT
HMGB1 is ubiquitously present in the cell nucleus and highly conserved among 
species. It is released by necrotic cells and actively secreted by immune cells in the 
extracellular environment, where it behaves as a DAMP (Damage-Associate Molecular 
Pattern). Up to now all studies addressing the role o f HMGB1 in wound healing have 
been carried out either in vitro or using pharmacological inhibitors. To assess the 
relative contribution of leukocyte HMGB1 and of passively released HMGB1 we have 
set up an ad hoc animal model. In this system, haematopoietic cells selectively lack 
HMGB1 by transplanting Hmgbl+I+ or Hmgbl'1' foetal livers into WT recipients. The 
role of leukocyte HMGB1 in tissue repair has been analyzed after skeletal muscle 
damage. I have used histological and magnetic resonance imaging (MRI) to non- 
invasively evaluate muscle inflammation and tissue architecture. In the absence of 
Hmgbl, there is a lower number of regenerating fibres at day7 after injury and an 
aberrant repair with smaller fibres at day 15. In vitro no differential effects of Hmgbl'1' 
and Hmgbl+I+ macrophages are detected on satellite cells differentiation/fusion, 
suggesting that events taking place in vivo are independent of the direct 
macrophage/satellite cell cross talk. No obvious differences are observed in the extent 
of leukocyte infiltration, as assessed both by cytofluorimetric and MRI analysis, 
suggesting that leukocyte Hmgbl is not required for the attraction of inflammatory 
cells. qPCR unveils a role for leukocyte Hmgbl in the production of angiogenic stimuli 
such as Ang2 and TNFa, probably in a hypoxia-dependent manner. Accordingly, the 
number of CD31 cells is dramatically reduced in the absence of leukocyte Hmgbl. 
Collectively our data suggest that HMGB1 secreted by leukocytes guides muscle 
regeneration through a paracrine role on vascular bed reconstitution.
[282 words]
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INTRODUCTION
1. The homeostatic response of tissues to injuries
Injured tissues are generally able to heal (1,2). Wound healing is a complex process 
that requires the interaction between multiple cell types and involves panoply of distinct 
molecules (3). Within minutes from tissue injury endogenous “danger” signals, 
cytokines and chemokines are released from parenchymal and incoming inflammatory 
cells. A regulated interplay between immune cells, endothelial cells and stem cells is 
needed to complete heal tissue (4).
1.1 Inflammation controls tissue healing 
The first line of defence after injury or infections is polymorphonuclear cells 
(PMNs), the most abundant being neutrophils (4). They arrive within minutes from 
tissue damage. The primary role of these phagocytic cells is to recognize, eat and kill 
invading microbes and/or to remove damaged cells and debris in preparation for tissue 
repair. They efficiently kill microbes thanks to specific metabolic enzymes such as the 
phagocyte NADPH oxidase (NOXs) and nitric oxide synthases (NOSI and NOSIII). 
Moreover they encapsulate an impressive number of proteases in defined intracellular 
compartments named granules (5). The major antimicrobial strategies used by 
neutrophils are:
• Phagocytosis, which comprises confining microbes in specialized 
phagosome compartments and their elimination
• Degranulation, which releases antimicrobial molecules at the site of 
infection/injury
• Neutrophil Extracellular Traps (NETs) formation. NETs are 
composed of decondensed chromatin decorated with granular and 
cytoplasmic proteins. NETs prevent microbe spreading out o f the site
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of entry, while apparently limiting the collateral tissue damage from 
granular contents and promoting synergy between granular and 
cytoplasmic proteins (6)
Macrophages, either resident in the tissue or recruited from circulating 
monocytes, are the second in line of defence against invading microorganisms and 
injuries (4). Progressively the number of neutrophils decreases and macrophages 
become the predominant infiltrating cells (7). Macrophages and neutrophils cooperate at 
the site of tissue injury or infection. The two cell types have both overlapping and 
complementary functions. Both are professional phagocytes even if  macrophages have a 
limited anti-microbial potential. Macrophages have a longer lifespan and distinct tissue 
localization. However macrophages and neutrophils cluster at the site of 
inflammation/injury following networks of chemotactic stimuli. These networks are 
initiated by resident macrophages together with epithelial and endothelial cells. 
Neutrophils, which are recruited first, prompt macrophage recruitment. Neutrophil 
secrete molecules, such as intra-granular proteins, that foster macrophage pro- 
inflammatory function (8). Macrophages eat dead neutrophils at the site o f damage, thus 
suppressing the production of pro-inflammatory mediators and facilitating the 
resolution of inflammation and tissue healing (7). The first evidence for a pivotal role of 
macrophages in wound healing has been reported in guinea pigs. Treatment with 
macrophage antiserum and glucocorticoids slowed cutaneous wound healing (9-11). 
More recent reports have confirmed the observation in mice in which macrophages are 
ablated using genetic tools. In those mice skin wounds fail to repair when macrophages 
are ablated at early time points after damage induction (Figure 1). The wound heals 
correctly when macrophages are depleted during terminal phase o f tissue healing (9, 
11). The phenomenon has been confirmed also in other pathophysiological settings, like 
acute muscle repair (2).
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Figure 1 -  Mice depleted o f macrophages (DTR-DT) display a defect o f  re-epithelialization at 
day5 after wound (11).
Most wound macrophages derive from circulating monocytes. Upon arrival at 
the injured site monocytes rapidly acquire macrophage features, expressing CD206 
(mannose receptor 1), while maintaining some monocyte features (Ly6 C and dectin-1). 
At least two monocyte subsets have been described in mice. Inflammatory macrophages 
are characterized by Ly 6 Chlgh, CCR2hlgh, CX 3 C R 1 Iow and migrate into wounds during 
early phase o f inflammation. A second population is characterized by Ly 6 Clow, 
CCR2low, CX 3 C R lhlsh expression and seems to egress later from circulation. In humans 
distinct populations are distinguished on the basis of the expression o f CD 16. 
CD 14 CD 16 cells express high levels o f CX3 CRI and may be orthologs o f Ly 6 Clow 
population in mice. The most abundant population is composed o f CD14+CD16‘ 
monocytes that express low levels o f CX3 CRI (12).
Macrophages resulting from the extravasating monocytes are known to be
plastic cells. The current paradigm distinguishes classical and alternative activated
macrophages. The former are endowed with pro-inflammatory and antimicrobial
capacities, the latter cooperate in tissue healing and parasitic infection clearance (7).
However these extreme phenotypes are not found in vivo where they show remarkable
plasticity and apparently continuously modulate and adapt their functions according to
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environmental cues. Thus the best way to describe macrophage phenotypes in vivo is a 
continuous spectrum of characteristics. Wound healing macrophages are considered as a 
population with unique characteristics, some peculiar of classically activated and some 
of alternatively activated macrophages (Figure 2, panel B). Similarly to classical 
activated macrophages they react promptly to environmental cues, such as danger 
signals or microbial products. One of the first innate signals generally released by 
granulocytes after tissue injury is IL4. The early exposure to IL4 prompts wound 
healing macrophages to upregulate arginase-I expression, a feature typical of alternative 
activated macrophages. The maintenance of a macrophage phenotype useful to tissue 
repair is strictly linked to generation of adaptive immune responses that in wound 
healing are instrumental for limiting inflammatory responses (8). Tt^-type immune 
responses are able to produce IL4 too and this is thought to be one of the main 
mechanisms for keeping macrophages in their pro-healing phenotype. For instance cells 
stimulated in vitro with IL4 are able to produce components of extracellular matrix. 
Also they secrete polyamines that suppress the clonal expansion of neighbouring 
lymphocytes (13).
Ml
Classically activated 
macrophages
M2
Alternatively activated 
macrophages
Classically activated 
macrophages
Regulatory
macrophages
Wound healing 
macrophages
Figure 2 - Colour wheel of macrophage activation. A. A monochromatic depiction of the 
previous nomenclature showing the linear scale of the two macrophage designations, Ml and M2. B. The 
three main populations of macrophages are arranged according to the three primary colours, with red
designating classically activated macrophages, yellow designating wound-healing macrophages and blue 
designating regulatory macrophages. Secondary colours, such as green, may represent tumour-associated 
macrophages, which have many characteristics of regulatory macrophages but also share some 
characteristics of wound-healing macrophages (8).
Macrophage polarization is crucial: a hyperactive matrix deposition activity 
results in fibrosis, while dystregulated pro-inflammatory activity may result in chronic 
inflammation and possibly autoimmunity. Several in vivo studies have demonstrated 
that macrophage phenotype in healing tissue can change over time. Regulatory 
macrophages can arise following distinct stimuli (8). For instance macrophages acquire 
the ability to secrete TGF|3 after phagocytosis of apoptotic cells (14), while stimulation 
of macrophages with immune complexes results in IL10 production. IL10 produced by 
T regulatory lymphocytes (Treg) is another trigger for the generation of regulatory 
macrophages (8).
1.2 Angiogenesis and vessel remodelling, indispensable steps fo r tissue healing
Macrophages in wound healing control the correct balance between pro- and 
anti-angiogenic factors (7). Accordingly, in mice depleted o f macrophages 
vascularization is reduced and abnormal (Figure 3). Defective angiogenesis frequently 
associates to a jeopardized healing (11, 15).
9
Figure 3 -  Angiogenesis is impaired in the absence of macrophages. DTR transgenic mice were 
subjected to excisional wounding and either left untreated (NT) or treated with DT (macrophage-depleted 
mice). Representative sections of wounds on day 5 post-injury showing impaired vessel formation in 
macrophage-depleted mice (bottom) compared with untreated mice (top). Arrows indicate the wound 
edges, ep, epithelium, gt, granulation tissue, ml, muscle layer. Dashed line indicates border between 
granulation tissue and subcutaneous muscle layer. Scale bar = 0.2 mm (11).
Also the endothelium is a plastic compartment that reacts to tissue needs in 
response to physiological and pathological environmental cues. Inflammatory events 
and extracellular matrix remodelling almost always accompany extensive reshaping of 
the vascular bed. Early after tissue injury, vascular permeability increases, driven by 
nitric oxide (NO), excess of Vascular Endothelial Growth Factor (VEGF) and an array 
of other mediators still not completely elucidated. The increased permeability allows 
inflammatory cells and plasma components to exit the bloodstream. Subsequently a 
vascular expansion occurs within adjacent avascular areas, possibly supporting the 
enhanced need of oxygen and nutrients associated to repair. Expansion of vascular bed 
is due to endothelial cell (EC) proliferation and migration (16). A nascent sprout from a 
pre-existing vessel comprises three EC types: tip, stalk and phalanx. Tip cell 
specification is essential for sprouting and is controlled both by inflammatory and 
extracellular matrix (ECM) molecules. Thus the tip EC is characterized by a unique
expression profile: it expresses molecules able to digest ECM (e.g. metalloproteinase 1) 
and receptors able to sense angiogenic factors (e.g. VEGF receptor 2 and 3) (17). Tip 
cells proliferate poorly and are highly specialized. Tip cells sense Tumour Necrosis 
Factor a  (TNFa) or bradykinin that induce lamellipodia and filopodia formation, 
typical of invading tip cells. Stalk and phalanx compartments are able to proliferate and 
they sense distinct stimuli to allow new vessel tube formation. Some of the factors 
involved in the process are known, such as Fibroblast Growth Factor-2, prostaglandin 
E2 and the chemokines CCL2 (Figure 4) (16).
Figure 4 -  Cartoon representing a growing vessel. Schematic representation of a tip cell (green) 
extending filopodia toward an angiogenic stimulus (red gradient), followed by stalk cells (pink), while 
phalanx cells (light blue) remain quiescent (17).
Hypoxia is one of the main stimuli for angiogenesis. Three hypoxia-inducible 
factor-a proteins (HIF-la, HIF-2a, HIF-3a) senses oxygen availability. If a hypoxic 
environment is present those short-living proteins are stabilized and translocate into the 
nucleus, where they associate with |3-subunits to activate target genes, binding to 
hypoxia responsive elements on DNA (Figure 5).
Stalk cells
Phalanx
cells
11
{  Ras. RAR*
\  MAPK '■
0 2. uKG ^  
Hypoxia, succinate, ROS? — | 
C O . succinate
PHDs
’rai sactivation
tlcngins
Prcteasome
Figure 5 - The classical 0 2 sensing pathway. H IF la  is hydroxylated through 0 2-dependent 
enzymes at P402 and/or P564. This modification is due to one o f  the three prolyl hydroxylase (PHD) 
enzymes, which mediate recognition o f the V H L-elongins complex and ubiquitination (Ub) o f  H IF la  
and hence targeting for proteasomal degradation. Tricarboxylic acid cycle intermediates such as succinate 
and fumarate, or perhaps mitochondrial reactive oxygen species (ROS), can inhibit the activity o f  PHDs, 
also stabilizing H IF la . Stabilized H IF la  associates w ith HIF1 (3, which binds to cognate hypoxia- 
responsive elements (HREs) in target genes (18).
Hypoxia is crucial for endothelial tip cell specification. VEGF and hypoxia 
promote Delta-like 4 (D114) expression in endothelial tip cells, which suppress 
endothelial cell fate into adjacent stalk cells by activating Notch signalling. Stalk cells 
are in charge o f carrying oxygenated blood, leading to downregulation o f VEGF and 
thus promoting negative feedback loop to stabilize vessels and ensure oxygen supply to 
regenerating tissue (19). Cytokines, such as IL6 and TGF|3 have been involved in 
angiogenesis. In tumour models o f glioblastoma IL6 seems to increase cell invasion 
through angiogenesis promotion (20). Moreover the action o f IL6 has been related to 
the efficacy of some anti-angiogenic therapies in patients with ovarian clear cancer 
cells; its action may be related to the hypoxic status o f the tumour and to HIF pathway 
activation (21). In vitro, TGF|3 promotes the organization of EC in tube-like structure in 
three-dimensional collagen gel culture. Moreover TGFf3 in vivo stimulates angiogenesis 
at local sites o f injection. TGF|3 also regulates the synthesis o f other pro-angiogenic 
factors such as Platelet-Derived Growth Factor (PDGF) (22).
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Anti-angiogenic factors are also needed to ensure correct tissue vascularization 
and repair. Thrombospondins (TSPs) are a family of five matricellular proteins able to 
guide ECM synthesis and remodelling. TSPs have been associated with ECM 
organization and modulation of bioavailability of growth factors implied in 
angiogenesis, such as basic Fibroblast Growth Factor (bFGF), TGF|3 and VEGF (19).
To sense the surrounding microenvironment ECs rely on the angiopoietins 
system (23). Angiopoietins are vascular morphogenesis related proteins that play a 
pivotal role in controlling vessel homeostatic functions. The ligand-receptor system 
comprises two receptors (Tiel and Tie2) and four ligands (Angl, Ang2, Ang3 and 
Ang4). Tie receptors are expressed mainly by ECs, haematopoietic stem cells and a sub­
population of pro-angiogenic tumour-associated macrophages. Angiopoietins have been 
originally identified as Tie2 ligands. So far no specific Tiel ligand is known. Several 
cell types constitutively express Angl, including pericytes, fibroblast and smooth 
muscle cells. In contrast Ang2 is expressed almost selectively by ECs. It is barely 
expressed by quiescent ECs, while it is rapidly upregulated upon EC activation. Both 
FGF2 and VEGF are potent inducer of Ang2 expression (24).
Angl and Ang2 bind to the same extracellular domain of the Tie2 receptor. 
Upon engagement o f Tie2, Angl is able to trigger receptor autophosphorylation. This is 
followed by PI3 Kinase activation that results in phosphorylation and activation of Akt. 
Akt in turn blocks the activity of the forkhead transcription factor FKHR-1. This 
cascade of events leads to the stabilization of the endothelium, with survival of 
quiescent ECs and consequent block of Ang2 production. It seems that the Angl-Tie2 
interaction is constitutively required to control vascular quiescence and to maintain 
endothelium. Ang2 expression is tightly regulated. mRNA encoding for Ang2 is 
virtually absent in quiescent endothelial cells. Its expression is under the control of 
several endotheliotropic factors (e.g. FGF2, VEGF and TNFa) but also of 
environmental cues (e.g. hypoxia or superoxides). Ang2 protein is contained in
endothelial cell Weibel-Palade bodies, ready for release in the extracellular space. 
Stimuli for Ang2 secretion are for example thrombin and histamine. Released Ang2 is a 
potent signal to activate endothelium and it primes ECs to be responsive to cytokines, 
thus further enhancing ongoing inflammatory response (Figure 6) (24).
Outside Tiel
Inside
Angl: 
Stabilization 
Survival 
Quiescence
Angl
\
O O\ng2
Tic2
/  \
5K Ab
1 i
PI3 in2
AKT NF-kB
1 \
FKHR1 Ang2:
Destabilization
Activation
Figure 6 - Angiopoietins signalling regulates quiescent and activated endothelial-cell phenotype. 
Angl signalling is constitutively required for endothelial cell survival and quiescence. Ang2 antagonism 
destabilizes the endothelial cell (yellow box) thereby rendering it responsive to stimulation by 
inflammatory and angiogenic cytokines (24).
Ang2 has also other effects on ECs that are context-dependent. In the presence 
of VEGF it facilitates angiogenesis, while its absence promotes vessel regression. Ang2 
overexpression in vivo also promotes wound healing (24).
Angiogenesis is essential for the synthesis, deposition and organization o f a new 
ECM. ECM components in turn guide fibroblast migration. Infiltrating macrophages 
secrete molecules such as FGF and TGF|3 that also favour conversion of fibroblasts to 
myofibroblasts, the cell type apparently needed for wound closure (25). Thus 
inflammation, angiogenesis and re-epithelialization are strictly interconnected.
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1.3 Inflammation influences the activation o f endogenous stem/progenitor cells 
in injured tissues
Skin wound healing is the general paradigm used to described molecules and event 
involved in tissue healing, including activation of local regenerative response in 
parenchymal cells. However the study of other tissues may be informative.
Following injury an acute inflammatory response arises in the lung. To repair the 
tissue epithelial cell spreading and migration is needed (Figure 7). Inflammation 
produces several molecules involved in this process:
• Members of the epithelial growth factor and fibroblast growth factor families 
(e.g. TGFP, Hepatocyte Growth Factor - HGF, Epidermal Growth Factor - 
EGF and Insulin-like Growth Factor -  IGF1)
• Chemokines (e.g. CCL2)
• Interleukins (e.g. IL2, IL4, IL13)
• Prostaglandins (e.g. PGE2)
These factors controls processes involving ECM remodelling and chemoattraction 
of resident and distant stem cells to the site o f injury (26).
Elaboration of ECM
Differentiation
Reversal of EMT?? Resolution
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Figure 7 - Processes involved in epithelial repair in the airways. Injury (1) initiates activation of 
macrophages (M) to activated macrophages (AM) and the recruitment of immune cells, (2), mesenchymal 
stem cells (MSC), or niche stem cells (NSC). Soluble factors (S) (3) act on epithelial cells and fibroblasts, 
which spread and migrate (4) closing the wound and establishing intact barrier function. TGF-|3 signalling 
results in trans-differentiation of epithelial cells to myofibroblasts (MY), and in a further elaboration of 
ECM. During resolution (6), immune cells disappear from the site of injury, macrophages are deactivated 
and epithelial cells terminally differentiate (7) (26).
Also upon renal injury a robust and productive acute inflammation is elicited. 
Inflammation stimulates resident progenitor cells to proliferate (27). Skin, lung and 
kidney share the signalling pathways through which progenitor cells are able to exit Go 
phase of cell cycle to enter into Gi and then into S and G2 phase, the Rho GTPases, the 
MAP kinase and the Wnt/|3-catenin (25-27).
In tissues of different origin like the myocardium IGF1, EGF and HGF are the main 
effector molecules on progenitor cells. Also in cardiac tissue they act in combination 
with cytokines such as IL6 and TNFa (28).
Even if  the effector molecules are conserved among tissues of distinct origin, the 
induction of the inflammatory response is different. In the case o f epithelia the 
disruption of the barrier allows microbes to enter the body (25-27). In the case o f heart 
damage inflammation is normally sterile (28). What can be a good model to investigate 
the role of immuno-derived molecules in condition of sterile injury?
2. Skeletal muscle damage and repair as a paradigm o f sterile injuries
To define the dynamics of tissue repair in vivo we need an appropriate model. 
Skeletal muscle damage is a very interesting and potentially useful pathophysiological 
sterile condition for the study of immuno-derived molecules in tissue repair.
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2.1 The ABC o f muscle 
Adult skeletal muscle is composed by myofibres, long, cylindrical cells containing 
multiple nuclei that are typically located in the periphery of the fibre. To generate the 
syncitium monucleated myoblasts fuse together and organize their cytoplasm to 
generate sarcomeres, the contractile functional unit of muscle. Ancestors o f myoblasts 
are satellite cells, resident muscle stem cells typically located in the subsarcolemma, 
between the fibres and the basement membrane (Figure 8) (29).
@  Muscle spindle o  Satellite cell
@  Nerve o  Interstitial cell
Lymph vessel C  Myonudeus
Q  Myofiber -C— Fibroblast
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Figure 8 -  Anatomical location of satellite cells and relationship with other muscle resident cell 
types (30).
A sheath of connective tissue, the epimisium surrounds the whole muscle. It extends 
inside the muscle to form septi around multiple fibres and it is called perymisium. 
Finally, each single muscle fibre has around its own connective tissue sheath, the 
endomisium. Connective tissue allows the blood and lymphatic vessels to come in and 
out from the tissue. Each muscle fibre contains myofibrils with a diameter o f around 
0,5-2 pm. In each myofibrils contractile units called sarcomers are present. In normal 
muscle inflammatory cells are completely absent, making inflammatory infiltrate a 
hallmark of muscle damage (Figure 9) (31).
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Figure 9 -  Hematoxylin and eosin staining o f the healthy skeletal muscle o f a C57B1/6 mouse (see 
methods).
Skeletal muscle effectively regenerates after an acute damage. The regenerative 
ability o f skeletal muscle has long been known, as well as the presence o f inflammatory 
cell infiltration in damaged muscle (32, 33). It is interesting to understand how the 
muscle enacts an efficient repair process. An early hypothesis has been that new 
myofibres are generated via budding o f myotubes from existing, injured fibres (32). 
Following studies demonstrated that this rapid repair occurs through the differentiation 
and subsequent cell fusion o f myogenically specified mononuclear precursor cells 
contained within the population of satellite cells described above. Alexander M auro in 
1961 proposed that satellite cells could represent a population o f “dormant myoblasts” 
left over from embryonic muscle development and capable o f recapitulating the 
developmental program of skeletal myogenesis in response to muscle injury (34). 
Subsequent studies in both chicken and mouse demonstrate that multinucleated 
myotubes could indeed be generated in vitro from single myogenic precursor cells: in 
vz'vo-labelled and cultured in vzYro-labelled satellite cells have been shown to participate 
in the regeneration o f damaged muscle, contributing almost exclusively via fusion with 
pre-existing myofibres (35). Pulse-chase experiments using tritiated thymidine to label 
dividing cells indicate that DNA synthesis among sublaminar nuclei is limited to 
satellite cell nuclei, and that “true” muscle nuclei do not undergo mitosis. These 
approaches result in the labelling o f a relative low number o f satellite cells, indicating
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their general quiescence in a physiological condition. However, even in the absence of 
muscle injury, some DNA labelled in the pulse phase eventually appears in myofibres in 
the chase phase, indicating a basal capacity of these cells to incorporate into adult 
muscle fibres (36). These studies are the basis of our current view of satellite cells as the 
primary mediators of postnatal muscle growth and repair. These cells respond to 
regenerative cues, such as injury or exercise, by proliferating to form myoblasts, that 
can undergo a limited number of cell cycles before terminally differentiating and fusing 
to form multinucleated myotubes (Figure 10) (35).
mroTUBEf
Figure 10 - Muscle regeneration via satellite cell fusion process (Adapted from (35)).
Satellite cell behaviour following tissue damage is quite well defined. The response 
to damage is orchestrated by transcription factors of the basic helix-loop-helix family. 
The process of regeneration can be dived into three stages, each of which is defined by 
the expression of specific factors. The first is the proliferative stage, in which satellite 
cell population expands. Quiescent and early-activated satellite cells express Pax7. 
During the first phase, satellite cells start expressing MyoD and Myf5. The second 
phase is the differentiation, in which the transcription factors MRF4 and myogenin are 
activated and Pax7, MyoD and Myf5 expression persist. MRF4 and myogenin drives
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the expression of muscle specific genes that are required to enter the last phase, the 
fusion, in which the mature myofibre is formed (Figure 11) (30).
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Figure 11 - Satellite cell differentiation genetic program (30).
2.2 Accessory, non-muscle derived cells actively participate to muscle 
regeneration
The view that satellite cells proliferate, differentiate and fuse to regenerate muscle 
has been challenged in the past few years. It has become clear that most progenitors in 
distinct tissues rely on microenvironmental cues generated by accessory cells, local 
signals and stromal structures. The regulatory effects of such cell populations mainly 
influence satellite cell proliferation and differentiation. For instance it has been 
discovered that inflammatory cells are not merely phagocytes that remove damaged 
fibres, but represent active and necessary players that generates signals that acts at 
distinct stages of satellite cells life cycle (29). Tissue resident progenitors with 
localization similar to satellite cells are endowed both with fibrogenic and adipogenic 
potential. They proliferate upon injury and secrete a number of trophic factors (37).
Acute muscle damage is a model o f sterile injury with prototypic inflammatory 
responses composed by neutrophils, macrophages and T lymphocytes. Fine tuning of 
such an effective immune response and molecules involved in the cross-talk with
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muscle cells are still poorly defined (29). Neutrophils appear in damaged muscle within 
few hours from damage, peak at 24 hours post-injury and then rapidly decline. 
Macrophages appear later, peak at day3 after damage and persist for several days after 
which they gradually disappear (38). Myeloid cells are likely to influence muscle repair 
both in a direct and in an indirect way. In fact they can perturb the proliferation, 
differentiation and fusion o f satellite cells or they can act on third parties, such as 
mesenchymal cells or endothelial cells (29).
Neutrophils play a controversial role. They have two major pro-regenerative 
functions. They degranulate and secrete proteases that digest the extracellular matrix 
(ECM) and secrete pro-inflammatory cytokines that recruit macrophages, the main 
actors in muscle repair. ECM remodelling is crucial step to set the stage for subsequent 
repair. Moreover neutrophils have a high phagocytic ability. Depletion of neutrophils in 
a mouse model o f acute damage results in accumulation o f tissue debris and slower 
muscle regeneration (39). However neutrophil infiltration is followed by a marked 
respiratory burst and free radicals release, that may cause additional damage to fibres 
(40).
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Figure 12 - Delayed repair in skeletal muscle is induced in macrophage-depleted mice. Nx = noxetin, a 
toxin used to induce acute muscle damage, as well as cardiotoxin. DT = Diphtheria Toxin, used to induce 
macrophage depletion, d = day post injury. Mice used here are genetically engineered to have the 
Diphtheria Toxin Receptor (DTR) under the control of CD l ib  promoter. When administered, DT kills 
specifically C D llb+cells, so macrophages (2).
Macrophages are key players in muscle regeneration. Depletion of 
monocyte/macrophages using CDllb-DTR genetic system results in failure of healing 
of acutely damaged muscles (Figure 12) (2).
Part of the contribution of macrophages to the repair of damaged muscle may rely 
on their ability to remove all debris. In 1990 it was demonstrated in a rat model that 
macrophages modulate immunological and inflammatory responses rather than only 
acting as scavenger cells and that they display different characteristics in the various 
phases of muscle repair (41). As mentioned, macrophage heterogeneity is dictated by 
environmental stimuli. The pro-/anti-inflammatory macrophage paradigm is sound and 
generally well accepted. However in vivo study only partially recapitulates in vitro 
characteristics of polarized macrophages (8). In our laboratory we have characterized 
the phenotype of infiltrating macrophages at distinct time points after muscle injury, in 
a model of cardiotoxin induced local and sterile damage. Early- and late-phase 
macrophages in healing skeletal muscle display features of both pro- and anti­
inflammatory macrophages. As pro-inflammatory macrophages they phagocytose tissue 
debris and dead fibres and they secrete pro-inflammatory cytokines such as TNFa in 
early phase after tissue injury. However they also express scavenger receptor molecules, 
such as CD 163 and CD206, typical of anti-inflammatory cells (Figure 13).
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Figure 13 - M acrophage characteristics in injured and regenerating muscles (42). In the first column 
untreated muscles are shown. Day3, 7 and 10 after cardiotoxin injection are shown in the subsequent 
columns.
Phagocytosis possibly contributes to switch macrophages into fully anti­
inflammatory cells, able to secrete anti-inflammatory cytokine (e.g. IL10), pro- 
myogenic (e.g. IGF1) and pro-angiogenic factors (e.g. VEGF). Those macrophages can 
sustain proliferation, differentiation and fusion o f satellite cells (29, 42, 43). All factors 
secreted by macrophages should be tightly regulated according to their function. For 
example early-phase macrophages release factors mainly involved in satellite cells 
activation and proliferation, while late-phase macrophages sustain fusion and 
differentiation (43). A clear example is Platelet Derived Growth Factor (PDGF). In 
muscle it is secreted early after injury by endothelial cells and platelets and by 
macrophages late after injury. In early phases o f muscle injury PDGF promotes satellite 
cell activation, migration and proliferation, while limiting differentiation. In late phase 
o f tissue repair it sustains angiogenesis, thus promoting healing. Degranulating platelets 
release TGF|3 just after injury and it recruits monocyte/macrophages (44) and inhibits 
satellite cell differentiation to allow the correct expansion o f the regenerative population
(45, 46). Later in repair TGFp is secreted by late-phase macrophages and orchestrates 
the ECM remodelling and angiogenesis. Finally it acts in an autocrine-paracrine manner 
to promote PDGF secretion by macrophages. Excess of TGFp causes fibrosis and loss 
of function of the repairing muscle (43). The last factor described is 1GF1. IGF1 
receptors are abundantly expressed in skeletal muscle (44). IGF1 is both a circulating 
hormone released by liver and a local autocrine/paracrine factor secreted by muscle 
cells and macrophages. In the latter case it is highly expressed throughout the 
regenerative process and it promotes proliferation, differentiation and fusion of satellite 
cells (47). Local IGF1 has hypertrophic and hyperplasic effects, since it increases both 
the number of myonuclei per fibre and the protein synthesis inside the fibre. IGF1 
engages IGF1 receptor type I on satellite cells and on regenerating fibres activating at 
least three intracellular signalling pathways: (i) the MAPK pathway; (ii) the PI3K 
pathway; (iii) the calcium-clamodulin dependent kinase pathway (48). Local IGF1 is 
released both by early-and late-phase macrophages, and thus is active all throughout the 
repair phase (43). The proliferative effect is evident early after damage. This is likely to 
happen since IGF-1 has a negative effect on myoblast differentiation when in 
combination with TNFa, typically secreted by early-phase macrophages (49). A 
plethora of factors released both by early- and/or late-phase macrophages are active in a 
similar manner during muscle regeneration such as Hepatocyte Growth Factor (HGF), 
Fibroblast Growth Factor 2 (FGF2), IL6 and IL10 (44).
Interestingly not only macrophages act on muscle, but the muscle also influences 
macrophages, for example by releasing molecules that promote macrophages invasion. 
Chemoattractiveness of myogenic cells is highest immediately after they are activated to 
proliferate and declines as the muscle begins to differentiate. Among the molecules that 
could account for this attraction effect MCP1/CCL2 is one of the most studied. The 
elevated expression of MCP1/CCL2 soon after injury and its ability to serve as a 
muscle-derived chemoattractant for macrophages in vitro have contributed to growing
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interest in chemokines in regulating communication between muscle and macrophages 
after injury (50).
In skeletal muscle damage, i.e. in condition of sterile injury, the homeostatic 
response of tissue to injury is surprisingly similar to that of an infected tissue to microbe 
invasion. How is the inflammatory response elicited in sterile condition and why the 
resulting response is so similar to the microbial-induced one?
3. Hmgbl in homeostatic responses to tissue injury
Inflammation is classically conceived as response to infections that represent a 
threat for body/tissue homeostasis (51). In the self-non-self model, foreign (non-self) 
molecules foster innate as well as adaptive immunity. Innate immunity in this scenario 
is then viewed as a controller and regulator of adaptive immune responses (52). In such 
a model the recognition of foreign signals is entrusted to Pathogen Recognition 
Receptor (PRRs) that distinguish among distinct Pathogen Associated Molecular 
Patterns (PAMPs). Innate immune cells exploit this pattern recognition system to trigger 
or select specific T and B cells responses. However empirical evidence indicate that 
trauma, cancers, radiation or chemical injuries elicit sterile inflammation even in the 
absence of microbial components (51). The “danger” model assumes that the immune 
responses are governed from within, responding to endogenous danger signals released 
by distressed cells. Embracing the danger model view, what really matters is not 
whether the signal is from exogenous (non-self) or endogenous (self) origin, but 
whether the signal is dangerous or not (52). By analogy with PAMPs the endogenous 
danger signals are referred to as DAMPs (Danger Associated Molecular Patterns). 
Danger signals are also referred to as alarmins to indicate their role in alerting immune 
system after tissue damage (51). PAMPs and DAMPs induce similar responses (1). 
Several danger signals have been described so far, such as Heat Shock proteins, SI00 
proteins and HMGB1 (see Table 1). They all share some features:
• They are rapidly released by necrotic cells
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• Cells of the immune system can secrete these signals without dying, often 
using specialized secretion systems
• They recruit and activate innate immune cells by interaction with specific 
receptors on these cells (e.g. Toll-like Receptors, TLRs)
• They cooperate to restore tissue homeostasis (51)
3.1 The ABC o f HMGB1
HMGB1 is a small protein (215 amino acids long) that has been initially 
identified as a nuclear factor. It is composed by two L-shaped domains, named HMG 
boxes A and B and by a 30 residues long acidic tail (Figure 14). The three domains are 
connected by short linker peptides. HMGB1 is ubiquitously expressed in virtually all 
cell types and tissues, albeit at distinct levels (53) and it is highly conserved among 
species (99% identity in mammals). The BoxA and BoxB share a limited amino acid 
identity but have some similarity in the structure (54).
N
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Figure 14 -  Schematic view of HMGB1 structure (54).
HMGB1 binds to DNA without sequence specificity in the minor groove and 
facilitates a number of nuclear transaction, such as transcription, replication and V(D)J 
recombination. It interacts with a number of nuclear proteins, such as p53 and NF-kB 
and TBP (TATA Binding Protein). Once bound to DNA, HMGB1 bends it with angles 
of 90° or more. This activity facilitates the assembly of protein complexes onto DNA. 
HMGB1 also binds DNA at the site of entry or exit of nucleosomes, thus allowing DNA 
sliding on nucleosomes (53). HMGB1 is highly mobile within the nucleus and binds 
both to euchromatic and heterochromatic DNA domains (55).
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3.2 Necrotic cells releases HMGB1
Necrotic cells releases HMGB1, which elicits inflammatory responses both in 
vitro and in vivo (54). When cells undergo apoptotic cell death HMGB1 remains strictly 
associated to the apoptotic chromatin, at least during the first phase of the process 
(Figure 15) (55).
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Figure 15 - Chromatin association of HMGB1 in living and dead HeLa cells. Both the cell 
culture supernatant (S) and the cells (P) have been analyzed by SDS-gel electrophoresis. Histones have 
been visualized by Coomassie blue, HMGB1 by immunoblotting or immunostaining with antibody to 
HMGB1, DNA by DAPI. Scale bars, 7.5 pm. A. Living cells expressing HMGB1-GFP, imaged by 
differential interference contrast and in green fluorescence. B. Interphase cells after permeabilization. C. 
Necrotic cells without permeabilization. D. Apoptotic cells with permeabilization (55).
HMGB1 is indeed a highly motile molecule inside the nucleus of living cells. In
contrast HMGB1 mobility in apoptotic cells is near to zero. The link between dying cell
DNA and HMGB1 is not required for apoptosis, since Hmgbl'7' embryonic fibroblast
has similar susceptibility to apoptosis respect to Hmgbl'7' cells. Moreover apoptotic
DNA has been demonstrated to be a sort of “sink” for HMGBl. In fact recombinant
HMGB1-Cy5 relocated into the apoptotic nucleus of Hmgbl'7’ fibroblast. The
27
interaction between HMGB1 and apoptotic DNA seems to be dependent on post- 
translational modification of hystones and chromatin modification, while it is 
independent of DNA fragmentation, typical event of apoptotic cell death (55).
Later reports however have clearly demonstrated that during late phase of 
apoptosis and in particular during post-apoptotic necrosis, a fraction of HMGB1 is 
released possibly in association with nucleosomes derived by caspase-dependent 
nuclease activation (56). These HMGB1 -nucleosomes complexes may represent a 
preferential substrate for autoimmunity (57). Of importance, released HMGB1 directly 
elicits TNFa release from monocytes (55) and in a model of massive acetaminophen- 
induced liver necrosis HMGB1 neutralization strikingly reduced the extent of liver 
inflammation. Thus HMGB1 has been identified as one of the main diffusible signals 
for necrosis (55).
The HMGB1 released by necrotic cells is an endogenous immune adjuvant that 
elicits antigen-presenting cells (APCs) maturation. Maturation of APCs in case of 
microbial infection is regulated by TLRs. They recognize microbial patterns and induce 
the overexpression on APCs of MHC class I and class II antigen and co-stimulatory 
molecules. In sterile injuries, however, endogenous adjuvant might exist to induce 
immune responses. HMGB1 when released by necrotic cells has been demonstrated to 
be an endogenous immune adjuvant. In vitro human dendritic cells (DCs) have been 
exposed to supernatants from either wt or Hmgbl'7' embryonic fibroblasts. The latter 
fails to upregulation of co-stimulatory molecules on DCs (58).
In vivo the adjuvant role has been verified on lymphoma (RMA cell line) tumour 
model. RMA necrotic cells are poorly immunogenic and fail to vaccinate animals to 
react against subsequent tumour challenges. When RMA necrotic cells have been 
injected alone, in fact, most o f the mice challenged with live RMA cells developed 
lymphoma. However mice are protected from tumour development when vaccinated 
with both wt necrotic fibroblast supernatant and apoptotic RMA. The protection has
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been less effective when apoptotic RMA are co-injected with supernatants from necrotic 
Hmgbl'7' fibroblasts (58).
3.3 Inflammatory cells actively secrete Hmgbl
HMGB1 has been previously implied in inflammatory response to septic shock 
and lung inflammation (59-61). Serum HMGB1 levels peak 16-32h after treatment with 
LPS (Figure 16, left panel). Consistently, in vitro LPS induces TNFa and IL-1 secretion 
by monocyte/macrophages within minutes from stimulation, while the production of 
HMGB1 is delayed at 18-24h after stimulation. Treatment in vivo with blocking 
antibodies for HMGB1 dramatically reduces the mortality of LPS challenged mice 
(Figure 16, right panel). HMGB1 levels in sera of patients with severe infections 
correlate with poor survival (59).
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Figure 16 -  On left panel accumulation of HMG-1 in serum of LPS-treated mice is shown. Male 
Balb/C mice (20 to 23 g) have been treated with LPS [10 mg/kg, intraperitoneally]. Serum has been 
assayed for HMG-1 by immunoblotting; the detection limit is 50 pg. On right panel survival curve of 
mice treated with anti-HMGBl antibodies is shown. Delayed administration of anti-HMGB-1 protects 
against LPS lethality in mice. Male Balb/C mice (20 to 23 g) have been randomly grouped and treated 
with an LD100 of LPS. AntiBHMG-1 or pre-immune serum (0.4 ml per mouse) has been administered at 
2,24, and 36 hours after LPS (59).
The release of HMGB1 by LPS-stimulated macrophages is calcium dependent and 
regulated by calcium/calmodulin-dependent protein kinase la  (CaMK la ) (62). Results
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obtained in sepsis models have been confirmed in a model of endotoxin-induced acute 
lung injury. Subsequently to LPS intratracheal administration massive neutrophil 
recruitment and TNFa and IL1|3 production occur. The treatment with anti-HMGBl 
antibodies reduced the oedema and the neutrophil recruitment while do not affect the 
early production of TNFa and ILlp (60). Moreover TNFa itself triggers HMGB1 
secretion by monocytes (59).
HMGB1 is now well accepted as a late-mediator of local and systemic sepsis. 
Further highlighting its extracellular role two questions arise:
i) how is it relocated from the nucleus to the cytosol?
ii) how is it secreted?
Cytokines are normally externalized through the endoplasmatic reticulum-Golgi 
route. Some of them, however, lack a signal peptide and are processed in a non- 
canonical pathway. The prototypic leaderless cytokine is ILlp that translocates into 
secretory lysosomes and is secreted upon exocytosis. Secretory lysosomes are defined 
as calcium-regulated secretory organelles that share features of both secretory granules 
and lysosomes. Leukocytes and platelets are particularly enriched in these organelles. 
HMGB1 is a leaderless protein; therefore it was hypothesized that it could follow the 
secretory granule pathway as ILip. This has been actually demonstrated in monocytes 
stimulated with LPS: HMGB1 translocates from the nucleus to the cytoplasm, where it 
is observed as punctuate staining at the periphery of cells (Figure 17). Biochemical 
approaches have helped in defining those compartments as organelles belonging to the 
endolysosomal compartment. No HMGB1 has been observed in early endosomes. In the 
secretory lysosomes it has been observed a partial co-localization of HMGB1 with ILip 
(63).
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Figure 17 - Immunofluorescence analysis of HMGB1 in resting and LPS-activated monocytes. 
Monocytes, freshly isolated (A) or cultured for 18 h with LPS (B), have been stained with ethidium 
homodimer-2 (nucleus) and anti-HMGBl antibody (HMGB1, green channel) and analyzed by confocal 
microscopy. Two sections of the same cells (peripheral and central) are shown, which allows the nuclear 
(central) and cytoplasmic (peripheral, absent at time 0, and evident after 18 h of activation) staining to be 
appreciated. The merged images verify the almost complete co-localization of HMGB1 and nucleus at 
time 0 (A, yellow), which decreases after LPS activation (B) (63).
Actively secreted HMGB1 is molecularly distinct from HMGB1 active in the 
nucleus. Using proteomic and bioinformatic tools it was demonstrated that secreted 
HMGB1 is hyperacetylated into two critical clusters of lysines. Moreover two cryptic 
nuclear export signals were identified in the protein. The acetylation at the C-terminal is 
necessary and sufficient for HMGB1 export from the nucleus but it is dispensable for 
localization in secretory granules that are released upon specific stimuli (64).
A second pathway of HMGB1 export exists. Pro- IL1(3 is cleaved in the cytoplasm 
by caspase 1. Caspase 1, in turn, is produced by cleavage of pro-caspase 1. Pro-caspase 
1 processing takes place in large protein complexes named inflammasome. They are 
organized on nucleotide-binding oligomerization domain-like receptor (NLR) protein 
scaffolds. NLRs probably sense microbial components (PAMPs) as well as endogenous 
danger signals (DAMPs). The related NLR family member Nalp3 mediates pro-caspase
1 processing upon contact with PAMPs. It has been hypothesize that HMGB1 could be 
processed into Nalp3 inflammasome upon monocyte/macrophage activation. In 
macrophages primed with LPS and stimulated with uric acid Nalp3 inflammasome is 
activated and promote caspase 1 activation. Mice lacking caspase 1 are resistant to 
endotoxemia, as well as wt mice treated with anti-HMGBl antibodies. In wt mice 
injected with LPS a peak of serum HMGB1 is reported; on the contrary in caspase 1 
deficient mice no increase in circulating HMGB1 was observed (Figure 18) (65).
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Figure 18 - LPS-induced endotoxemia requires caspase 1-dependent HMGB1 release, but not the 
caspase 1 substrates IL-ip and IL-18. A, WT, caspase V1', and IL-lb^'/IL-lS7' mice have been injected 
i.p. with 40 mg/kg LPS and their survival has been monitored (left panel). Caspase 1 absence causes a 
decrease in circulating HMGB1 levels during endotoxemia. WT and caspase 12/2 mice have been 
injected i.p. with either saline or 40 mg/kg LPS, 24 h before serum was collected to measure secreted 
HMGB1 (65).
When murine bone marrow derived macrophage (BMDM) of murine origin are
primed with LPS and then given a second stimulus to activate inflammasome they
activate a Nalp3 and caspase 1 dependent HMGB1 secretion. Upon S. typhimurium
infection, BMDMs activate Ipaf inflammasome. Ultimately also Ipaf inflammasome
leads to caspase 1 activation. It has been demonstrated that upon contact with the
bacterium BMDMs secrete HMGB1 in an inflammasome and caspase 1 dependent
manner. Caspase 1 inhibitors block both Nalp3- and Ipaf-dependent HMGB1 secretion,
thus demonstrating that caspase 1 is required for HMGB1 secretion upon
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inflammasome activation. The secretion of HMGB1 is not dependent on the cleavage 
activity of caspase 1 on HMGB1, as it is for ILip (65).
It has been recently been proposed that an autophagy-based unconventional 
secretion of substrates exists. Whereas basal autophagy blocks inflammasome and ILip 
secretion, induced autophagy acts in the opposite way. ILlp co-localizes with LC3 in 
the cytoplasm of cells with autophagy induced by starvation. On the contrary inhibition 
of autophagic flux leads to block of ILip secretion in BMDM. Starvation also induces 
HMGB1 secretion in an Atg5 (i.e. autophagy) -dependent manner. Interestingly some 
stimuli that induce inflammasome, such as nigericin, also induces autophagy and 
autophagy-related HMGB1 secretion, pointing out a strict cooperation between distinct 
non-canonical secretory pathways (66).
4. Functional effect of Hmgbl
The logical questions that follow are: (i) are there specific receptors for 
extracellular HMGB1? (ii) what is the role of extracellular HMGB1?
4.1 RAGE and TLRs are HMGB1 receptors
Before the discovery of HMGB1 as a late mediator of sepsis another protein,
amphoterin, was known to bind the surface of embryonic rat neurons to enhance neurite
outgrowth. HMGB1 and amphoterin turned out to be the same protein. Amphoterin, i.e.
HMGB1, binds to the Receptor for Advanced Glycation End products (RAGE) to exert
its action on neurons (67). RAGE is a member of the immunoglobulin superfamily and
it is expressed on endothelium, vascular smooth muscle cells, mononuclear phagocytes
and the central nervous system. The extracellular domain is composed by one “V” type
and two “C” type domains and is very similar to neural cell adhesion molecules. The
RAGE binding site of HMGB1 resides in the BoxB domain and the interaction is
mediated by the VI domain of the receptor. RAGE is a multi-ligand receptor that can
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bind also advanced glycation end products (AGEs), SI00 proteins, heparin and 13- 
amyloid protein (Figure 19) (68).
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Figure 19 -  Structure of RAGE and signalling pathways induced by HMGB1 binding to RAGE. 
The cytosolic tail is required for RAGE-mediated intracellular signalling. The distal Ig domain (VI) binds 
HMGB1 and other RAGE ligands. Ligand binding to RAGE regulates gene expression through the 
transcription factors NF-kB, CREB and SP1 (68).
The affinity of HMGB1 for RAGE can be modulated by other HMGB1 ligands. 
HMGB1 has a heparin-binding site at the N-teiminus of the BoxA domain. Heparin 
binding causes a conformational change in HMGB1 and decreases the affinity o f the 
protein for RAGE (69). NF-kB is activated downstream RAGE engagement by 
HMGBl. The activation of NF-kB depends both on Ras activation and p38 MAP kinase 
(MAPK)-Erkl/2 signalling. Activation of the MAPK pathway ultimately leads to 
phosphorylation and degradation of inhibitor of NF-kB (IkB). Interestingly, a NF-kB 
binding site has been described in the RAGE promoter, thus creating a possible 
positive-feedback loop (70). Rac and Cdc42 are activated in consequence of 
HMGB1/RAGE engagement by HMGB1 to favour neurite outgrowth and several 
migratory mechanisms (67). RAGE in vitro caused NF-kB translocation into the 
nucleus.
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HMGB1 enhances NF-kB nuclear translocation in a TLR4 dependent manner, 
and both TLR2 and TLR4 are required to activate transcription of NF-kB target genes 
(71). A physical interaction of HMGB1 with TLR2 and 4 has been demonstrated using 
fluorescence resonance energy transfer (FRET) (72). Both receptors are present on 
endothelial cells and on innate immune cells. After HMGB1 interaction, adaptor 
proteins such as myeloid differentiation primary response protein 88 (MyD88) and TIR- 
domain containing adaptor protein (TIRAP) bind to TLR2 and TLR4. MyD88 recruits 
members of the IRAK family that activate downstream TRAF6 kinase. The signalling 
pathways culminated in NF-kB activation through phosphorylation and degradation of 
its inhibitor IkB. TLR2/4 engagement also causes p38 MAPK pathway activation. 
Therefore there may be intersections between RAGE and TLRs signalling (Figure 20).
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Figure 20 - Convergence of TLR and RAGE signalling. Schematic representation of signalling 
events mediated by TLR and RAGE receptor activation is reported. The outcome of the interplay between 
TLR2/4 and RAGE is likely to differ between cell types (70).
HMGBl/TLRs interaction have been proposed to control HMGB1 inflammatory 
activity, while RAGE signalling could be mainly related to HMGB1 migratory activity. 
However, this may be an oversimplification (70).
35
HMGB1 also binds to the carbohydrate chains of syndecans, particularly it has 
been demonstrated for syndecan-1. Syndecans are able both to transduce intracellular 
signal as independent membrane receptors and to act as co-receptors for integrins or 
growth factors. The HMGB1/proteoglycans interaction has been proposed to be 
involved in the pro-migratory action of HMGB1 (68).
4.2 HMGB1 effect on cell migration
Pro-migratory ability of extracellular HMGB1 has been one the first effects to 
be described (68).
HMGB1 favours the migration of vascular smooth muscle cells: in vitro, cells 
have been treated with small interfering RNA for TLR4 and in the absence of TLR4 no 
migration has been observed, indicating that the migration is TLR4 dependent. It has 
been also established that the effect passes through the signalling of PI3K and Akt (73). 
The same pro-migratory effect has been observed with rat smooth muscle cells and the 
effect is MAPK dependent (74).
HMGB1 triggers the migration of stem and precursor cells as well. For instance 
recombinant HMGB1 induces vessel-associated stem cells migration (75). In our lab we 
have demonstrated that HMGB1 produced by human inflammatory macrophages 
induces vessel-associated stem cell migration and that BoxA, the antagonist of HMGB1 
for RAGE binding, reduced the effect (Figure 21) (76). When injected into the muscles 
of dystrophic mice, HMGB1 triggers vessel-associated stem cell migration in vivo in a 
RAGE dependent manner (77). HMGB1 also triggers migration of rat myoblasts in 
vitro in a RAGE-dependent and p38 MAPK-dependent fashion (78).
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Figure 21 -  Human mesoangioblast migrate in response to pro-inflammatory macrophage 
conditioned media (M l) in a Boyden chamber assay. When media are supplemented with the HMGB1 
antagonist BoxA mesoangioblast migration is dramatically reduced (76).
Other progenitors that rely on HMGB1 for their migration are endothelial 
precursor cells. Endothelial precursor cells express RAGE and TLR2 but not TLR4 and 
HMGB1 increases their migration onto fibronectin and fibrinogen. Cells respond to 
HMGB1 with a bell-shaped dose-response curve; anti-RAGE but not anti-TLR2 and 4, 
blocking antibodies inhibit migration. Thus HMGB1 induces endothelial precursor cell 
migration on matrix protein in a RAGE-dependent manner (79).
HMGB1 modulates the response to chemoattractants o f several innate immune 
cells. For example freshly isolated adherent monocytes express HMGB1 and RAGE. 
Although a direct chemotactic role o f HMGB1 on monocytes has been excluded, 
HMGB1 increases trans-endothelial migration of monocytes. Experiments performed in 
the presence of anti-RAGE antibodies have identified an autocrine and paracrine role of 
HMGB1/RAGE interaction in trans-endothelial migration of human monocytes (80).
In vitro experiments I have performed before starting my PhD project indicate
that murine monocytes migrating to a known chemotactic stimulus, such as
CXCL12/SDF1, secrete HMGB1 and that the secreted HMGB1 acts in an
autocrine/paracrine manner to facilitate migration. A similar effect has been observed in
dendritic cells (Figure 22). In supernatants of migrating monocytes CXCL12 elutes in
the same fraction of HMGB1, indicating a possible physical interaction of the two
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proteins (81). These results have been recently confirmed and expanded in an elegant 
studies by Schiraldi et al. (82). Previous data from my lab have linked the facilitating 
role of HMGB1 on dendritic cell migration with the RAGE-mediate upregulation of 
chemokines receptor for homing at lymphoid organs, such as CCR7 and CXCR4 (83).
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Figure 22 -  HMGB1 is required for murine dendritic cell migration in response to a 
chemoattractant (CXCL12). Boyden chamber assay is performed in the presence or in the absence of 
HMGB1 antagonist BoxA (81).
There is a single report indicating an anti-migratory effect o f HMGBl. This 
seems to be peculiar of enterocytes in inflammatory situations. In this paper the authors 
demonstrate that HMGB1 expression is increased in necrotizing enterocolitis both in 
human and mice. They have cultured human enterocyte cell lines on a monolayer and 
scratched the plate. Enterocytes are left closing the wound in the presence or in the 
absence o f HMGB1 inhibitor. When HMGB1 is blocked enterocyte migration is 
reduced and the scratch fails to close. Therefore HMGB1 is necessary for enterocyte 
migration in a 2D model. On enterocyte TLR4 expression is upregulated in condition of 
damage. The expression in human enterocytes o f a dominant negative form of TLR4 
demonstrates that HMGB1/TLR4 interaction functions to inhibit enterocyte migration 
(84).
4.3 HMGB1 effect on inflammatory responses in health and disease
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HMGB1 is required for the development and progression o f inflammation in a 
number of disease conditions (85). HMGB1 senses intracellular nucleic acids and elicits 
primary response thus defending the host genomic integrity from pathogen invasion. 
This is a general mechanism of innate immunity present in all cells and is mediating a 
type I interferon mediated responses (86, 87).
HMGB1 is important in the pathogenesis of diseases such as systemic lupus 
erythematosus (SLE) and epilepsy. Pathogenetic factors for SLE are increased cell 
death with defect of apoptotic bodies clearance that in turn trigger breaking of immune 
tolerance to nuclear antigens. In such processes HMGB1 binds the “eat me” signal 
phospatidylserine impairing clearance of apoptotic cells. Moreover it inhibits integrin- 
dependent recognition of apoptotic material by macrophages (85). Finally HMGB1- 
nucleosomes complexes are recognized by TLR2 eliciting pro-inflammatory cytokine 
production. Those complexes inhibit immune tolerance to nuclear components such as 
double strand DNA even in non-SLE prone mice (57). In epilepsy inflammation is one 
of the worsening factor in several types of seizures. HMGB1 increases and anticipates 
the seizures induced by a chemoconvulsant in a TLR4 dependent manner. Epileptic 
events promote HMGB1 release, creating a dangerous vicious cycle (88).
There are several mechanisms by which HMGB1 accomplishes its immune- 
regulating functions in health and disease. It targets both innate and adaptive immune 
cells and I am going to briefly review the effects of HMGB1 on monocyte- 
macrophages, antigen presenting cells and T lymphocytes. Human peripheral blood 
mononuclear cells have been exposed to HMGB1 and it stimulated the release of TNFa, 
IL6, IL8, M IPla, MIPip but not IL10 or IL12. Also LPS is able to induce the same 
molecules on human molecules. However, while LPS is active in lh after stimulation, 
the HMGB1 effect is delayed, accordingly to its role as late-mediator of sepsis (61).
The demonstration that HMGB1 physically interacts with microbial moieties 
and modifies its function should be taken into account interpreting these results.
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HMGB1-TLR4 interaction is anyway able to induce inflammation per se. The minimal 
portion of HMGB1 required to induce pro-inflammatory cytokine release is located in 
the B box (position 89-108) (89). Specifically cysteine in position 106 (C l06) is 
required to have HMGB1/TLR4 binding and induction of TNFa release by 
macrophages.
The interaction occurs between HMGB1 B Box and the TLR4/MD2 complex. 
After binding HMGB1 is internalized with the complex itself. The redox state is a 
possible regulator of HMGB1 extracellular activity. The critical role o f C l06 has been 
discovered using mutagenesis approach in all the residues within the B box (90). Very 
recently other critical residues have emerged as crucial regulators of HMGB1/TLR4 
binding. Other two cysteines are highly conserved in HMGB1, C23 and C45. They can 
form a disulfide bond in recombinant HMGB1 (rHMGBl) able to induce the release of 
inflammatory cytokines from human macrophages (i.e. TNFa) and NF-kB nuclear 
translocation (see molecule in line 1 of Table 1). Up to now these modifications have 
not been described for the native molecule. When rHMGBl is exposed to reducing 
agents no pro-inflammatory activity is detected (molecule in line 3 of Table 1). The 
same outcome is observed when the protein is oxidized and terminal oxidation 
modifications are present either on C23, C45 or C l06 (molecule in lines 2 and 4 in 
Table 1). It is now clear that the a specific redox state of the three cysteines is required 
for the TNF-stimulating activity o f HMGB1 (see Table 1, line 1) (89).
In the extracellular environment HMGB1 forms complexes with exogenous and 
endogenous molecules to enhance their activity on immune system (1). For example if  
rHMGBl without inflammatory activity forms complexes with LPS it increases by 100- 
fold the magnitude of cell response to LPS itself. A similar potentiating effect is 
described when HMGB1 binds to TLR2 or TLR9 ligands, such as in the case o f nucleic 
acid mentioned before (91). HMGB1 can bind also endogenous molecules such as 
IL la, IL1|3 (92), CXCL12 (81) and nucleosomes (57). A better understanding o f the
40
biology of HMGB1 interactions with other molecules is of pivotal importance to 
understand which receptor is used by which complex to enhance cytokine effect. In 
general HMGB1/molecule X complexes signal mainly through molecule X receptor, 
meaning that the synergistic effect of HMGB1 results from quantitative rather than 
qualitative changes in intracellular signalling pathways (91).
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Table 1 -  Distinct redox state of HMGB1 have distinct outcomes on its pro- 
inflammatory activity (89).
HMGB1 is a key molecule in the cross-talk between professional antigen
presenting cells such as dendritic cells (DCs) and T cells (93). To initiate T cell-
dependent immune responses immature DCs internalize antigens by phagocytosis,
macropinocytosis or endocytosis and upregulate the expression of co-stimulatory
molecules (e.g. CD80, CD83, CD40). DCs process ingested antigens and present them
in association with major histocompatibility complex molecules (MHC) class I and
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class II. Finally DCs secrete signals useful for T cell proliferation and polarization. 
HMGB1 has been proposed to affect all of these steps (94). HMGB1 released by 
necrotic cells has been demonstrated to participate to DC maturation, by enhancing co­
stimulatory but not MHC expression in a RAGE dependent manner (58). Maturing DCs 
are in turn able to secrete HMGB1 (95).
Secreted HMGB1 interacts with RAGE and activates p38 MAPK and NF-kB 
pathways. This leads to proliferation and survival of na'ive CD4+ T cells. Moreover 
maturing DCs start secreting IL12, thus promoting Thl polarization on nai've CD4+ T 
cells. The ability of DCs to secrete HMGB1 is acquired after starting of the maturation 
process by either PAMPs or cytokines. Immature DCs do not secrete HMGB1 (95).
HMGB1 also exerts a direct pro-proliferative effect also on CD8+ T cells (94- 
96). To activate adaptive immune responses maturing DCs must reach the T cell zone of 
lymph nodes. Our group have demonstrated that maturing DCs depend on RAGE for 
homing to draining lymph nodes. Bone marrow-derived DCs from RAGE-/- mice failed 
to reach draining lymph nodes when co-injected with complete Freund adjuvant in the 
footpad of wt mice. On the other hand wt DCs perfectly reach the lymph nodes both of 
wt and RAGE -/- mice, thus confirming that integrity of RAGE signalling, and possibly 
of HMGB1/RAGE interaction is required for maturing DCs homing to lymph nodes 
(Figure 23) (97).
NK interaction also regulates DC maturation and function. NK cells trigger 
immature DCs to secrete IL18 in the synaptic cleft between the two cells. DC activated 
NK cells are able to secrete HMGB1 in the surrounding environment. Secreted HMGB1 
participate, as mentioned, to DC maturation but also it protects DC from lysis by 
activated NK cells (98).
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Figure 23 - Selective migration of RAGE"7" DCs to draining lymph nodes. MRIs of wild-type 
(bottom panel) or RAGE"7' mice 48 h after injection into the footpads of DCs labe-led with SPIO. DCs 
have been either wild type (right panels) or RAGE'7' (left panels). The black spot (i.e. migrating DC) is 
highlighted by the white circle and is lacking only in DC RAGE'7' transfer into either wt or RAGE '7' mice 
(97).
HMGB1 satisfies three key requirements for a DAMP. In fact HMGB1 is:
(i) readily secreted upon necrosis or cell stress;
(ii) segregating in apoptotic cells, at least during early-apoptosis;
(iii) important for DC maturation and T cell activation (94).
A further feature of a DAMP is to favour tissue repair. To prompt tissue healing,
HMGB1 should be involved in the termination of the inflammatory response. In CD24'7'
mice the acetaminophen-induced liver necrosis results in the death of animals because
of excessive inflammatory response to injury. The increased susceptibility has not been
observed in a model of sepsis, indicating that CD24 distinguishes among PAMPs and
DAMPs. CD24 binds to HMGB1 and other DAMPs, such as heat shock protein 70 and
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90. The interaction between DAMPs and CD24 negatively regulates their stimulatory 
activity on immune response by inhibiting NF-kB activation (99).
A recent report has pointed out that treating mice with HMGB1 reduces the 
percentage of CD25+FoxP3+ regulatory T cells in the spleen and this seems to be a 
TLR4 dependent mechanism (100). The actual relevance of these event remains to be 
established.
4.4 HMGB1 promotes wound healing
HMGB1 involvement in wound healing has been first investigated in the skin. In 
an excisional wound on the back of mice HMGB1 blockade with BoxA impaired 
healing (Figure 24). In vitro studies confirmed that HMGB1 has a positive role on 
migration but not proliferation of keratinocytes. Conversely treating diabetic ulcer with 
HMGB1 ameliorates repair, while no effect of BoxA has been observed on the repair 
kinetics of diabetic mice. This is not contradictory since the effect of BoxA blockade 
depends on the local availability of native HMGB1 that in diabetic mice is greatly 
reduced (3).
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Figure 24 -  Treatment of skin wound with BoxA results in delayed wound healing (3).
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HMGB1 is able to induce fibroblast collagen deposition inside the wound in a 
RAGE dependent fashion. The contribution to matrix remodelling could be one of the 
mechanisms involved in the pro-healing function of HMGB1 (101).
HMGB1 has been implied also in cardiac repair after myocardial infarction 
(102). In a model of total heart ischemia post-ischemic treatment with HMGB1 
improves the cardiac function, diminishes the infracted area and reduces pro- 
inflammatory cytokines (e.g. ILip and IL6) levels in the infracted hearts (103).
HMGB1 also facilitates repair in myocardial infarction. HMGB1 acts directly on 
cardiac c-kit+ stem cells, which express RAGE. In mice subjected to myocardial 
infarction proliferation of c-kit+ cells increases in vivo. Moreover scar is virtually absent 
in hearts treated with HMGB1 as compared to untreated ones since the infracted area is 
almost completely regenerated, with a general amelioration of the cardiac function. 
HMGB1 promotes c-kit+ cells differentiation towards cardiomyocytes. However while 
HMGB1 is migratory in vitro, ex-vivo no migratory effect is observed (104). The 
indirect effect of HMGB1 on migration of c-kit+ cells can pass through fibroblasts. 
Human cardiac fibroblasts express RAGE. They have been stimulated in vitro with 
HMGB1: released soluble factors induce cardiac stem cells proliferation and migration 
in vitro. HMGB1 pro-healing function is exerted through conditioning of 
microenvironment cell components (105).
HMGB1 plays a role also in post-ischemic wound healing, as indicated by 
studies in a peripheral ischemia model on both normal and diabetic mice. Normal mice 
have been subjected to ischemia of hind limbs and muscles have then been treated with 
BoxA to block HMGBl. HMGB1 blockade reduces reperfusion of the ischemic limb 
and a worse repair (Figure 25). It has been observed that the number of CD31+ cells (i.e. 
vessels) is reduced in BoxA-treated limbs. A similar effect has been obtained with 
injection of anti-VEGF antibodies. In diabetic mice HMGB1 levels in the ischemic limb
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are reduced. The number of necrotic or apoptotic fibres is not different in normal and 
diabetic mice, as well as the number of infiltrating cells. However the number of CD31+ 
cells is reduced in diabetic mice. HMGB1 restores reperfusion in diabetic mice and the 
number of CD31+ cells is normalized as well (106).
after ttirgery day 7 day 14 day 21 day 28
Blood flow.
Blood Flow D Control + Vchiclo 
■Control + BoxA
-J Day
Figure 25 - Representative evaluation of the ischemic (right) and non-ischemic (left) hind limbs 
immediately after and on days 7, 14, 21, and 28 after surgery. Blood flow recovery is impaired in BoxA- 
treated mice compared with vehicle-treated mice (106).
Angiogenesis-activated endothelial cells have to migrate, proliferate and sprout 
into the stroma, leading to the formation of vascular loops and finally capillary tubes. 
HMGB1 in vitro enhances endothelial cell proliferation, migration and tube formation 
in a RAGE-dependent manner.
HMGB1 increases the repair of a disrupted endothelial cell monolayer through 
augmenting the sprouting activity in a RAGE dependent fashion (107). HMGB1 pro- 
angiogenic effect is at least partially heparin dependent (108). Also the pro-angiogenic 
effect of HMGB1 involves TLR4 signalling, fn a model o f coroidal neovascularization, 
local treatment with HMGB1 increases the number of vessels in normal mice while fails 
to induce vessel formation in TLR4'7' mice. Moreover peritoneal macrophages from
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control mice produce VEGF, bFGF and TGF(3 upon stimulation with HMGB1, while 
peritoneal macrophages from TLR4'7' mice fail (109).
Angiogenesis and lymphangiogenesis share many features. HMGB1 has been 
found also to increase proliferation, migration and tube formation of lymphatic cell lines 
in a time and dose dependent manner (110).
The so-called angiogenetic switch, the initiation of angiogenesis, is a key step in 
tumour progression and dissemination. It ensures the correct oxygen and nutrient supply 
to the growing tumour. It is promoted by the hypoxic microenvironment that is 
established upon initial tumour enlargement. Hypoxia triggers necrotic cell death of 
tumour cells and necrotic areas show increase expression of VEGF and their pro- 
angiogenic molecules (111).
5. Putting the puzzle together: what is the contribution of distinct sources of
Hmgbl to tissue repair? The need for a new animal model
5.1 HMGB1 and muscle repair 
HMGB1 and muscle repair are intimately linked to inflammation, and the features 
of the inflammatory response modulates HMGB1 activity. Appropriate inflammatory 
responses are needed for successful tissue healing. There are relative few studies 
pointing to a possible role for HMGB1 in muscle repair. HMGB1 has proved to be 
important in the repair of ischemia/reperfusion injury through control of vascularization 
and in cardiac repair through control of cardiac stem cell differentiation (102, 106). 
Moreover we and other have identified HMGB1 as a chemotactic molecule for 
unconventional myogenic cells such as mesoangioblasts (76, 77). HMGB1 has also an 
effect on myoblast proliferation, differentiation and migration (78).
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RAGE engagement leads to the expression of TGF(3 and PDGF (112). RAGE is 
expressed in skeletal muscle and it is developmentally regulated. It has a myogenic role 
when engaged by HMGB1 through MAPK signalling pathway. In contrast when 
engaged by S100B protein it has an apparently opposite action, at least in vitro (49). In 
a very recent paper it has been demonstrated that HMGB1/RAGE interaction controls 
satellite cell homeostasis. In Rage'7' mice the number of Pax7+ (i.e. quiescent) satellite 
cells is increased and it increases further following muscle damage. Regeneration is 
delayed of nearly one week in these mice, probably due to an excessive satellite cell 
proliferation, that inhibits differentiation. Pax7 overexpression indeed blocks myogenin 
expression, while RAGE engagement leads to its expression. Thus it appears that 
RAGE signalling physiologically represses Pax7 transcription in satellite cells by 
driving myogenin expression (113).
5.2 Limitations in HMGB1 study
Most of the studies cited have important limitations. The studies on 
ischemia/reperfusion model in normal mice have been carried out by injecting HMGB1 
pharmacological inhibitors into damaged muscle. In this case the outcome observed is 
the result of the total block of extracellular HMGB1, without dissecting the relative role 
of leukocyte-associated HMGB1 and HMGB1 passively released by dying fibres. In the 
case of diabetic mice and ischemia/reperfusion study, exogenous HMGB1 has been 
administered to mice. Thus the results obtained do not reflect directly the role of the 
endogenous protein (106). The same approach was used in the studies about skin and 
cardiac wound healing that thus present the same limitations (3, 104). The study on rat 
myoblast proliferation and differentiation is only in vitro (78), as well as the study about 
the role of macrophage-released HMGB1 in mesoangioblast migration (76). The paper 
on HMGB1 role in mesoangioblast migration in vivo has been carried out by injecting 
HMGB1-coated heparin beads into muscles, again not addressing the role o f the
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endogenous protein (77). The role of RAGE has been addressed in vivo but without 
distinguishing the two sources of HMGB1, the passively released by necrotic fibres and 
the actively secreted by inflammatory cells (49, 113). Finally the role of HMGB1 in 
driving MHC class I antigen overexpression in muscle fibres has been addressed on 
isolated fibres and with recombinant protein administered, thus avoiding the study of 
the endogenous protein (114).
5.3 An original mouse model to address HMGB1 dynamics in vivo
To better define HMGB1 role in tissue repair it would be necessary to establish:
• an appropriate sterile damage model to study the molecule in vivo. As described 
muscle damage is an ideal model. A better description of HMGB1 expression in 
acutely damage muscle is reported is section 1 of the RESULTS
• a mouse model in which HMGB1 is lacking selectively in the haematopoietic 
system, to dissect the relative role of leukocyte HMGBl. This model was not 
available at the beginning of my PhD project.
Theoretically a mouse with all the tissue wt and only the haematopoietic compartment 
Hmgbl'1' is needed. The easiest way to obtain such a model is to transplant a bone 
marrow from Hmgbl'1' donor into wt recipient. Unfortunately Hmgbl'1' mice are not 
viable and die short after birth because of severe hypoglycaemia. Even when injected 
with glucose they die few days after. Long-living pups die at three weeks of age and are 
smaller than their wt counterparts. Moreover they are deaf, blind, display marked 
kyphosis, bone and muscle atrophy (115). Thus they are not available nor for in vivo 
study nor to be used as bone marrow source for transplantation. We have decided to 
move to another source of haematopoietic precursors, the foetal liver. Foetal liver is the 
haematopoietic organ in late intrauterine life. We decided to use foetal liver at 
gestational day E14.5, reported as the peak of the liver haematopoiesis (116). In section
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2.3 of the RESULTS I will present the set up work to define the best condition to 
transplant foetal liver into adult, lethally irradiated recipient. The set-up work has been 
carried out on wt CD45.2+ foetal liver that have been transplanted into adult CD45.1+ 
recipient. In section 2.4 I will report the results I have obtained about muscle repair in 
mice transplanted with Hmgbl deficient and proficient foetal livers. Hmgbl'7" foetal 
liver have been obtained by crossing male Hmgbl+I' X female Hmgbl+I'. Thanks to this 
original model the relative role of leukocyte HMGB1 can be addressed in vivo in a 
sterile tissue repair model.
In the next section I am going to present several acute damage models described 
in literature, with some advantages and drawbacks, to explane why we have chosen the 
cardiotoxin-induced muscle damage model.
5.4 The choice o f an appropriate acute damage model
Four main methods to induce acute muscle injury on mice are reported in 
literature:
i) Exercise/contraction injury
ii) Glycerol intramuscular injection
iii) Ischemia-reperfusion injury
iv) Toxin(s) intramuscular injection
Each method has got its own peculiar characteristics. Herein I am going to briefly 
review and compare these methods to show why in the present study I have chosen the 
injection of cardiotoxin in the skeletal muscles of mice.
i) Exercise training consists of high-repetition, aerobic-type activity: swimming, 
treadmill running, and voluntary-wheel running. Exercise intensity ranges from 
submaximal exercise to maximal exhaustive exercise. The exercise protocols ranges 
from 1 wk to several months and the duration and type of the exercise-training protocols 
is from 2 to 60 min of swimming each day or 15 min to several hours o f treadmill
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running per day. Many of the studies allow the animals to exercise ad libitum on an 
exercise wheel (117). A large number of studies have shown that eccentric exercise 
causes injury in normal humans and animals (118, 119). Several studies have been 
performed to help elucidate the mechanisms and subsequent adaptation of skeletal 
muscle to contraction-induced injury. This information, theoretically, would help assess 
what types of training would be either beneficial or deleterious to muscle. Some authors 
proposed that microinjuries to the sarcolemma and their subsequent repair may be an 
important mechanism that regulates muscle atrophy, homeostasis, and hypertrophy. In a 
model of rat contraction injury even when no disruption of the sarcolemma was 
detectable by ordinary light microscopy, the presence of albumin within the muscle was 
an indication of microinjury to the sarcolemma. The microinjury to the sarcolemmal is 
an early form of exercise-induced injury. This injury could be repaired or, if  severe, 
progress to fibre necrosis (120). In the case of my project this is not the ideal model for 
several reason:
a. Lots of protocols are available. Each of them is very well characterised at 
histological but not at immunological levels. Few reports are available 
on the role of specific immune cell population. Since I have to dissect the 
role of tissue and leukocyte Hmgbl, this is a big limitation
b. All protocols described in literature are stressful for the animal, that 
before being submitted to exercise would have already undergone foetal 
liver transplantation after lethal irradiation
c. Repair kinetics are very variable among protocols described
ii) Glycerol injection is not as stressful as the exercise injury. The damage is obtained 
by direct administration of glycerol with a simple intramuscular injection. The damage 
is sterile and the repair is quick, since a structure similar to untreated muscle is restored 
in 28 days. However inflammatory cells are virtually absent in this model, as shown in 
Figure 26.
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Figure 26 - K inetic analysis o f glycerol induced muscle regeneration. H istological m odifications in 
skeletal muscle were analyzed by hem atoxylin-eosin-safranin staining after intra-m uscular injection o f  25 
pL  o f  glycerol 50% (HBSS, v/v) in the TA o f 3 month-old B6D2 female. Muscles w ere sam pled at 
indicated times and paraffin-em bedded before analysis. Scale bar = 100 pm  (121).
This model is used to study the pathophysiology o f fat deposition in muscle. The 
quantity o f fat deposition varies depending on the age, sex and strain o f the mouse
(121). Since we need to dissect the relative contribution o f muscle and leukocyte 
H m gbl this model cannot be used. The absence o f inflammation is a non-physiological 
event since normally skeletal muscle damage is accompanied by leukocyte infiltration
(122). In the ideal model to solve my biological issue there should be the restitutio ad
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integrum of the skeletal muscle. The presence of extensive fat deposition mirrors an 
aberrant repair process.
iii) Muscle damage due to ischemia-reperfusion is characterized by oedema, infiltration 
of inflammatory cells, and disruption of normal muscle cell architecture (123). 
Theoretically it would be the ideal model to address my issue. However skeletal muscle 
fibers are known to survive up to 4 hr of ischemia (124), so cellular injury is likely to be 
initiated only after a prolonged period of ischemia. This is the major limitation o f this 
model: to induce ischemia a long surgical procedure in general anesthesia is required. 
Furthermore, in studies in rodents a patchy pattern is observed with normal and necrotic 
muscle fibers (123).
iv) Toxins used to induce skeletal muscle damage, such as cardiotoxin or notexin, are 
small peptides of low molecular weight. Upon i.m. injection into mice, the toxin 
induces early morphological alterations in the periphery of muscle fibers, indicating that 
the plasma membrane is the first cellular structure to be affected. Afterwards, necrotic 
cells have a clumped appearance, which then changes to a more hyaline histological 
pattern. Removal of necrotic material by phagocytes around day 3 after injection is 
followed by skeletal muscle regeneration, with the presence of myoblasts, myotubes and 
fully regenerated myofibers. The resitutio ad integrum of the tissue is achieved by 
day30 from toxin injection. The toxin induces a rapid and drastic drop in muscle 
creatine and creatine kinase contents, as well as an increase in serum levels o f the 
enzymes lactic dehydrogenase and creatine kinase. Moreover, total muscle calcium 
increased significantly after toxin administration. The injection of toxins is non 
invasive, it is followed by a detectable and well characterized inflammatory reaction 
and the muscle is able to restore the original architecture in one month from the 
injection (2, 42, 125, 126). The major drawback of this model is that the hit is non 
physiological, as it would be in the case of exercise injury. Despite this I have induced 
acute damage by injection of a toxin, since it ensures me a quick, well characterized
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repair of an inflammatory, sterile damage. I have injected a mix o f long and short 
cardiotoxins from Sigma-Aldrich derived from the venom of the snake Naja 
mossambica mossambica. A brief description of the histological and immunological 
characteristics of the model is reported in the first section of RESULTS as well as a 
description of Hmgbl expression in this model.
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MATERIALS AND METHODS
1. Muscle damage induction and repair evaluation
All procedures involving animals are performed accordingly to the Institutional 
Animal Care and Use Committee (IACUC). Wild-type C57BL/6 female mice 8 weeks 
old (from Charles River Laboratories, Calco, Italy) were injected intramuscularly (i.m.) 
with cardiotoxin (CTX, 100 ptl, 10 pM within the quadriceps and 50 pL, 10 pM within 
the tibialis anterior [TA]) (Naja mossambica mossambica; Sigma-Aldrich, Germany). 
Mice were sacrificed at 1, 3, 7, 10, and 15 days after injury. Injured muscles were 
collected and frozen. Immunohistochemical and Immunofluorescence analysis have 
been performed as described later. Muscle damage, remodelling, and repair were 
evaluated by hematoxylin and eosin (H&E) on 6-pm-thick muscle sections.
2. BoxA treatment
At dayO CTX (50 pL, 10 pM, Sigma-Aldrich, Germany) and BoxA (diluted in CTX 
solution, 10 pg/TA, HMGBiotech, Milan, Italy) are co-injected into TA muscle. The 
treatment with BoxA is repeated i.m. every other day for the first week after damage. 
Then mice are treated i.m. at day9, 12, 14 and 24. Control mice (sham group) received 
the vehicle alone (saline solution) according to schedule. Mice are followed by MRI 
before treatment and at day 1, 3, 5, 6, 10, 14, 30. MRI procedure is described in the 
following paragraph. 6 or 7 mice are sacrificed at day7, 15, and 30. Three mice/group 
are sacrificed at day 1 and 3 for muscle weight analysis. Muscle are retrieved and 
weighted immediately after isolation.
3. Magnetic Resonance Imaging ("MRU
3.1 MRI acquisition
MRI acquisition were performed using a 7T horizontal 30 cm bore, 300.3 MHz unit
(Bruker, BioSpec 70/30 USR, Paravision 5.0, Germany), with a maximun 675 mT/m
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gradient, a maximum rise time o f 140 ps and with a linear MRI transmitter coil (inner 
diameter of 72 mm) and 1H rat heart receive-only coil array with four internal 
preamplifiers. The laser cross-hair positioning of mice was reproducible and operator 
independent. A Multi-Slice Multi Echo (MSME) T2 map with fat suppression was used 
(TR=1938 ms; TE=10,73/171,68; FOV=20x20; matrix=256x256 mm; spatial 
resolution=0,078x0,078 mm/pixel; NSA=4). The acquisition of the Diffusion Tensor 
Image (DTI) in 30 directions was performed using the following parameters: TR= 3750 
ms; TE= 33 ms; FOV=30x30; matrix=128xl28; NSA= 1; diffusion gradient 
duration=4ms; diffusion gradient separation=20ms and b value of 0 sec/mm or 700 
sec/mm2. The EPI-Diffusion Map was acquired with TR=3000 ms, TE=30 ms, 6 b value 
directions, diffusion gradient duration=7 ms, diffusion gradient separation=14 ms, 
NSA=2. The DTI and EPI-Diffusion Map sequences shared the same matrix size 
(128x128 mm) and the same spatial resolution (0,234 x 0,234 mm/pixel). All sequences 
were acquired with a slice thickness of 1mm and a gap of 1mm.
3.2 Data processing
For each mouse at each time point five subsequent slices have been considered. For 
each slice two regions of interest (ROI), one on the TA (damaged muscle) and one on 
the G (control muscle) were evaluated by two independent operators. For each mouse 
four serial sections of seven pm thickness with 30 pm interslice distance were collected 
and stained as described above. A semiquantitative (0 to 5) score for infiltrate 
evaluation was established and an expert pathologist evaluated blinded all sections. 0 is 
considered as not infiltrated muscle. 5 is the most infiltrate muscle. Muscle with 
intermediate infiltration levels are evaluated accordingly. The score was subsequently 
correlated with T2-rt. In the same sections a second blinded independent observer have 
counted the central-nucleated fibres. The average for each mouse was then correlated to 
fractional anisotropy (F.A.) from DTI sequence.
56
4. Foetal liver transplantation and chimerism assessment
Hmgbl heterozygous mice colony is propagated in the SPF Facility o f San Raffaele 
Institute. An Hmgbl heterozygous female and male are crossed. Foetuses at day E l4.5 
post coitum and livers are retrieved and smashed mechanically. After filtration on a 40 
pm cell strainer (BD Falcon, USA), single cell suspension from one foetal liver is 
resuspended in 200 pL of sterile saline solution and 100 pL/mouse are injected. 
Recipient mice are lethally irradiated (900nrad) the day before with an X-ray source 
(Gilardoni, Italy). Mice are kept in SPF condition all throughout the experiment. After 6 
weeks chimerism on peripheral blood (PB) is verified on PB from the tail vein. 100 pL 
PB/mouse are collected in 20 pL Heparin (Hospira, Illinois, USA; 5000 UI/mL). 30 
pL/FACS tube are dispensed. After addition of 50 pL blocking buffer (PBS+10% FBS, 
Lonza, Italy) and incubation at RT for 15 minutes, primary antibody is added: anti­
mouse CD45.1 PE (BD Bioscience, clone A20), anti-mouse CD45.2 FITC (BD 
Bioscience, clone 104), anti-mouse C D llb  APC (BioLegend, San Diego, CA, USA, 
clone Ml/70). Anti-CD45.1, CD45.2 and anti-CDllb have been added at a final 
concentration of 2 pg/mL and 5 pg/mL respectively. After washing red blood cells are 
lysed using lysis buffer (BD Bioscience). Cells are fixed in PFA 4% (Sigma-Aldrich) 
and stored at 4 °C until acquisition. BM cells have been flushed and cells are processed 
and labeled as above. Spleen and inguinal lymph nodes were incubated twice (30’ each 
at 37 °C) with collagenase A, B, D mix (Roche). The retrieved suspension is filtered. 
Single cells have been labeled and processed as above. Flow cytometry has been carried 
out with FACS-Canto flow cytometer and the Flow Jo Software v. 8.6.1 (Tree Star Inc., 
Ashland, OR, USA).
5. Flow cytometry on total muscle
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Muscles are dissociated by enzymatic digestion with collagenase type V (Sigma- 
Aldrich) (0.5 mg/ml) and dispase (Invitrogen, Life Technologies Europe, Paisley, UK) 
(3.5 mg/ml) at 37 °C for 40 min. Retrieved cells are labelled as above. Primary antibody 
is added and incubation is left 20’ at +4 °C. The following antibodies are used: anti­
mouse CD45.1 PE (BD Bioscience, clone A20), anti-mouse CD45.2 FITC (BD 
Bioscience, clone 104), anti-mouse, CD45 V450 (BD Bioscience, clone 30-F11), anti­
mouse Ly6G FITC (BioLegend, clone 1A8), anti-mouse CD lib  APC (BioLegend, 
clone M l/70), anti-mouse F4/80 PE (BioLegend, clone BM8), anti-mouse CD3 APC 
(BD Bioscience, clone 145-2cll), anti-mouse NK1.1 PerCP (BD Bioscience, clone 
PK136), anti-mouse CD19 PE (BD Bioscience, clone 1D3), anti-mouse CD86 PE (BD 
Bioscience, clone GL1). Final concentration for anti-CD45.1, CD45.2, CD45 and Ly6G 
is 2 p,g/mL. Final concentration for all other antibodies is 5 [ig/mL. To reveal purified 
anti-mouse CD 163 (Santa-Cruz Biotechnology, Santa Cruz, CA, USA, rabbit 
polyclonal) we have used anti-rabbit FITC secondary antibody BD Bioscience, goat 
polyclonal). After labelling cells are fixed in PFA 1%, washed and analyzed by flow 
cytometry using FACS-Canto flow cytometer and the Flow Jo Software v. 8.6.1 (Tree 
Star Inc.).
6. mRNA analysis
Muscle total cellular RNA is extracted using TRIZOL (Invitrogen), following the 
manufacturer’s recommendations. RNA (1 p,g) is used for quantitative polymerase 
chain reaction (PCR) analysis for first-strand synthesis of complementary DNA with the 
high capacity complementary DNA Reverse Transcription kit (Applied Biosystems) 
according to the manufacturer’s instructions.
Quantitative PCR is performed using SYBRgreen PCR Master Mix (Applied
Biosystems, Life Technologies Europe). Results are quantified using ABI7900 machine
(Applied Biosystems). The level of RNA is normalized to the corresponding level of
GAPDH messenger RNA (mRNA) for muscle lysates or total cells lysates. Sequences
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of primers (Primm, Milan, Italy) used in quantitative real-time PCR are as follows (5’ to 
3’ sequence): h ifla  (Fw: TCA AGT CAG CAA CGT GGA AG; Rv: TAT CGA GGC 
TGT GTC GAC); vegf]3 (Fw: CCT GGA AGA ACA CAG CCA AT; Rv: GGA GTG 
GGA TGG ATG ATG TC); ang2 (Fw: CAC AGC GAG CAG CTA CAG TC; Rv: 
ATA GCA ACC GAG CTC TTG GA); glutl (Fw: GCT GTG CTT ATG GGC TTC 
TC; Rv: AGA GGC CAC AAG TCT GCA TT); CAIX (Fw: GGA GTC CCT TGG 
GTT AGA GG; Rv: GAT GTC TAC CGG GGA CTG AA); myoD (Fw: ACG GCT 
CTC TCT GCT CCT TT; Rv: GTA GGG AAG TGT GCG TGC T); pax7 (Fw: GAC 
TCG GCT TCC TCC ATC TC; Rv: AGT AGG CTT GTC CCG TTT CC); myogenin 
(Fw: GAC ATC CCC CTA TTT CTA CCA; Rv: GTC CCC AGT CCC TTT TCT TC); 
igfl (Fw: GTG TGG ACC GAG GGG CTT TTA CTT C; Rv: GCT TCA GTG GGG 
CAC AGT ACA TCT C); tnfa (Fw: TCC CAG GTT CTC TTC AAG GGA; Rv: GGT 
GAG GAG CAC GTA GTC GG); il6 (Fw: CTC TGC AAG AGA CTT CCA TCC 
AGT; Rv: CGT GGT TGT CAC CAG CAT CA); illO (Fw: ATT TGA ATT CCC TGG 
GTG AGA AG; Rv: CAC AGG GGA GAA ATC GAT GAC A); gapdh (Fw: TCC 
ACT CAT GGC AAATTC AA; Rv: TTT GAT GTT AGT GGG GTC TCG).
7. Western blot analysis on CD45+ cells and total muscle lvsates
Cells are retrieved from damaged muscles at days 1, 3, 5, 7, 10 and 15 after
injection of CTX. Muscles are dissociated by enzymatic digestion as above. Cells
expressing the CD45 marker are purified using magnetic beads (Milteny Biotec,
GmbH). The purity is verified by flow cytometry after incubation with FITC-labelled
anti-CD45.2 mAb (final concentration 5 qg/ml; BD Pharmingen, clone 104). CD45+
infiltrating cells and whole muscle are lysed in Tris lOmM pH 8.0, NaCl 150mM,
Nonidet P40 1%, sodium dodecyl sulphate 0.1%, EDTA ImM, in the presence of
protease inhibitors cocktail [containing 4-(2-aminoethyl) benzenesulfonyl fluoride
(AEBSF), pepstatinA, E-64, bestatin, leupeptin, and aprotinin; Sigma-Aldrich]. Lysates
are centrifuged at 16,000g for 5 min at 4 °C. For Western blot analysis, equal amounts
59
of protein (20 pg) are resolved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis and transferred onto Immobilon-P (Millipore). After Ponceau S (Sigma- 
Aldrich) staining to verify correct transfer, membranes are saturated in Tris-HCl 20mM, 
pH7.6, NaCl 150mM (Tris-buffered saline [TBST]), containing non-fat milk 5% and 
Tween 20 0.1%. Mouse Hmgbl is revealed using mouse monoclonal anti-Hmgbl (final 
concentration 0.1 pg/ml, kindly provided by Dia.Pro. Diagnostic Bioprobes, Milan, 
Italy). To normalize results membranes are blotted using mouse monoclonal anti-|3actin 
(final concentration 0.1 pg/ml; Sigma-Aldrich, clone AC 15), or mouse monoclonal anti- 
GAPDH (final concentration 0.1 pg/ml; Sigma-Aldrich, clone GAPDH-71.1) 
antibodies. All antibodies were diluted in TBST 5% non-fat milk. Incubation was 
performed overnight at 4 °C for primary antibodies and lh at room temperature for the 
second-step reagents. Primary antibodies are revealed with HRP-conjugated secondary 
antibodies (final concentration 0.2 g/ml; GE Healthcare Europe GmbH) and a 
chemiluminescence kit (ECL, Western blotting detection reagents; GE Healthcare 
Europe GmbH).
8. ELISAs
For determination of the concentration of IL10, TNFa and IGF1 we have used 
DuoSet kit (R&D Systems) following manufacturer’s instruction. For determination 
of Hmgbl concentration we have used Shino Test Corporation (Tokyo, Japan) 
ELISA kit following manufacturer’s instruction. Data acquisition is performed on a 
Microplate Reader (Bio-Rad, Hercules CA, USA) and data analysis is performed 
using Microplate Manager Software (v. 5.2.1, BioRad). Data are expressed in 
pg/mL.
9. Immunohistochemistrv
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Frozen sections (7 pm thick) are fixed in paraformaldehyde (PFA) 4% (Sigma- 
Aldrich) for 10’ and washed twice in PBS. Endogenous peroxidase has been quenched 
using 0.1% H2O2 in methanol for 10’ at RT. After washing Avidin/Biotin blocking kit 
(Vector Laboratories) is used following manufacturer’s instruction. Sections are washed 
twice with PBS and blocked for lh at RT in PBS + 5% BSA + 5% goat serum. Primary 
antibodies are incubated overnight at 4 °C. To assess CD68 expression we used rat anti­
mouse CD68 (AbD Serotec) diluted 1:100 in blocking buffer. For CD31 we used rat 
anti-mouse CD31 (BD Bioscience, clone MEC13.3) diluted 1:100 in blocking buffer. 
To reveal CD68 and CD31 we used a goat anti-rat biotin-conjugated secondary 
antibody (eBioscience) diluted 1:300 in blocking buffer. Secondary antibody is 
incubated lh at RT and then revealed using streptavidin HRP and chromogen. 
Streptavidin HRP (1:200 in PBS, Invitrogen) is incubated 20’ at RT. Chromogen 
(NovaRed,Vector Laboratories) is prepared following manufacturer’s instruction and 
developed under an optical microscope (Nikon).
10. Immunofluorescence
10.1 Pax7 andMyoD staining
Frozen sections (10 pm thick), are fixed in PFA 4%, washed and subjected to 
antigen retrieval by incubation in boiling citric acid pH6 for 10’. Sections are then 
cooled on ice for 30’, left lh  at RT in PBS + 5% BSA (Sigma-Aldrich) +1%  normal 
goat serum + 5% FBS + 0.1% Triton X I00 (Sigma-Aldrich). Primary antibodies are 
incubated overnight at 4 °C. To detect Pax7 we have used the supernatant o f a mouse 
anti-Pax7 hybridoma (Developmental Studies Hybridoma Bank, University o f Iowa, 
Iowa City, USA) diluted 1:5 in blocking buffer; to detect MyoD we have used a rabbit 
anti-mouse MyoD polyclonal antibody (Santa Cruz Biotechnology) diluted 1:25 in 
blocking buffer. For Pax7 an AlexaFluor anti-mouse 488 antibody (Invitrogen) is used 
diluted 1:500. For MyoD an AlexaFluor anti-rabbit 594 antibody (Invitrogen) is used
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diluted 1:500. Nuclei are counterstained using Hoechst 33348 (Invitrogen) diluted in 
PBS and incubated for 10’ at RT. Mounting is performed using H2O and glycerol. 
Photographs are taken at 40x magnification on Nikon Eclipse 55i microscope (Nikon, 
Tokyo, Japan). Pictures were captured with digital sight DS-5M digital camera (Nikon) 
using LuciaG Software (Laboratory Imaging, Prague, CZ).
10.2 Hmgbl staining
Frozen section (10 pm thick) are fixed in PFA 4% (Sigma-Aldrich) for 10’ and 
washed twice in PBS. Sections are then left 2h at RT in blocking buffer: PBS + 5% 
BSA + 5% FBS + 0.1% Triton X100 (Sigma-Aldrich). Expression of Hmgbl is 
revealed using a polyclonal rabbit anti-mouse Hmgbl antibody (Abeam, USA) diluted 
1:500 and an AlexaFluor anti-rabbit 594 antibody (Invitrogen) diluted 1:500. Nuclei are 
counterstained using Hoechst 33348 (Invitrogen). Mounting is performed as above. 
Photographs are taken at 40x magnification on a Photographs are taken at 40x 
magnification on Nikon Eclipse 55i microscope (Nikon, Tokyo, Japan). Pictures were 
captured with digital sight DS-5M digital camera (Nikon) using LuciaG Software 
(Laboratory Imaging, Prague, CZ).
10.3 Myosin Heavy Chain (MyHC) and CD l i b  staining on cell culture
After 48 hours of differentiation (see 12.2) differentiated satellite cells are 
identified assessing the expression of MyHC. Cells are fixed for 15’ in PFA 4%, 
washed in PBS and blocked lh at RT in blocking buffer: PBS + 5% BSA + 5% FBS + 
0,1% Triton X I00. We have stained satellite cells with MF20 hybridoma supernatant 
diluted 1:5 in blocking buffer and macrophages with rat anti-mouse CD l ib  antibody 
(clone M l/70, BioLegend) diluted 1:500. Both antibodies are incubated overnight at 4 
°C. MyHC is revealed using AlexaFluor anti-mouse 488 antibody, CD l ib  is revealed 
using AlexaFluor anti-rat 594 antibody, both diluted 1:500. Nuclei are counterstained
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using Hoechst 33348. After washing, pictures are taken at 20x magnification. The 
InCell Analyzer 1000 (GE Healthcare) instrument has been used for high throughput 
acquisition (see 12.3).
11. Murine macrophage differentiation and polarization
11.1 Murine macrophage differentiation
BM is flushed from C57BL/6 female mice (6-8 weeks old, Charles River). BM 
progenitors are extracted as described (127). The cells are challenged with complete 
medium: a-MEM (GIBCO, Invitrogen) + 10% FBS + 100 ng/mL recombinant murine 
(rm) M-CSF (Miltenyi Biotec) and differentiated for 5 days in Petri dish for bacteria 
(BD Falcon), diameter 10 cm, splitted and cultured two more days in the same medium. 
The resulting macrophage population is referred to as “M0”.
11.2 Murine macrophage polarization
M0 macrophages are detached on ice using cold PBS and then resuspended in a- 
MEM (GIBCO, Invitrogen) + 10% FBS (Lonza). M0 cells are then counted. To obtain 
pro-inflammatory, Ml-like cells, M0 cells are resuspended at a concentration of 500 
000 cells/mL in a-MEM (GIBCO, Invitrogen) + 10% FBS + 50 ng/mL rmlFNy 
(PeproTech) and cultured for 48h. To generate anti-inflammatory, M2-like cells, M0 are 
resuspended in a-MEM (GIBCO, Invitrogen) + 10% FBS + 10 ng/mL rmlLlO (R&D 
Systems) + 10 ng/mL rm M-CSF (Miltenyi Biotec, GmbH) and cultured 96h, with half 
of the complete medium refreshed after 48h.
12. Satellite cell isolation, expansion and co-colture with murine macrophages
12.1 Satellite cells isolation and expansion
6 weeks old C57BL/6 female mice (Charles River) are sacrificed and TA,
quadriceps, gastrocnemius and triceps are retrieved. Muscles are dissociated by
enzymatic digestion with collagenase type V (Sigma-Aldrich) (0.5 mg/ml) and dispase
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(Invitrogen) (3.5 mg/ml) at 37 °C for 40 min. Digested cells are resuspended in IMDM 
(Gibco, Invitrogen) + 10% FBS. Cells from each mouse are plated into two separate 
tissue culture dish (10 cm diameter, BD Falcon) and maintained in incubator at 37 °C, 
5% CO2 for 2h. During pre-plating new tissue culture dishes are coated with collagen 
(Sigma-Aldrich) for 30’ at room temperature. Collagen is then retrieved from dishes. 
During the pre-plating phase contaminant cell populations (endothelial cells, fibroblasts, 
etc) adhere. Floating cells are retrieved and plated in Ham F10 medium (Sigma-Aldrich) 
containing 20% Hyclone (Gibco, Invitrogen). Cells from each mouse are plated into 
three collagen-coated dishes. Satellite cells are propagated at 37 °C, 5% CO2 until they 
reach confluence. Every 3 days half of the complete medium is refreshed.
12.2 Satellite cells differentiation
Proliferating satellite cells are detached using trypsin/EDTA cocktail (Lonza). 
Cells are then centrifuged (1500 rpm, 5’, RT), counted and plated into Matrigel (Sigma- 
Aldrich) coated multiwell plates. Typically, 100 000 cells/well are plated in 12 wells 
plate in 1 mL complete medium. Differentiation medium is DMEM (Lonza) + 2% horse 
serum (HS, Vector Laboratories). Complete differentiation occurs in 48h, at 37 °C, 5% 
CO2 . Satellite cells differentiation assay is performed also using 500pL of 
differentiation medium and 500pL of conditioned supernatants from polarized 
macrophages, either obtained from Hmgbl wt and Hmgbl KO FLT mice. As a control 
satellite cells are differentiated in 500pL differentiation medium + 500pL of a-MEM  
containing 10%FBS and the recombinant cytokines used for macrophage polarization 
(see 11.2).
12.3 Satellite cells -  Macrophages co-colture
Satellite cells are retrieved from collagen-coated dish using Trypsin/EDTA 
cocktail. Macrophages are detached using PBS + 5mM EDTA on ice. Cells are
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resuspended in a-MEM + 10%FBS. Macrophages and satellite cells are mixed at 1:1 
ratio into Matrigel coated 12 wells plate and cultured for 48h at 37 °C, 5% CO2 .
12.4 Differentiation assessment and quantification
Differentiated satellite cells are identified by MyHC expression as described 
above (see 10.3). For each well 20 to 30 photograph are taken using InCell Analyzer 
1000 at 20x magnification. Each condition is tested in double or in triplicate, as 
indicated in figure legend. Each photograph is manually counted clustering positive 
cells with one nucleus, positive fibres with 2 to 4 nuclei and positive fibres with more 
than 5 nuclei. Results are graphed as average ± standard deviation (SD) for each 
condition and each cluster of fibre size.
13. Statistical analysis
13.1 General
Data are expressed as means ± SD. Statistical analysis was performed using 
Student's t-test for unpaired data or one-way ANOVA followed by a Dunnett’s or 
Newman-Keulspost hoc test when appropriate. Values of p<0.05 were considered 
statistically significant (Graph Pad Prism, v. 4.0 Software, La Jolla, CA, USA).
13.2 MRI statistics
Data are expressed as means ± s.e.m.. Statistical analysis was performed using 
Student's t-test for unpaired data or one-way ANOVA when appropriate; correlation 
was evaluated using Pearson test (Prism 4.0, GraphPad Software, Inc.). Values of 
P<0.05 were considered statistically significant
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RESULTS -1
As mentioned in the INTRDUCTION the aim of my PhD project is to dissect the 
relative role of tissue and leukocyte Hmgbl in the context of sterile damage and repair. 
Acute skeletal muscle damage is often associated with excessive exercise or commonly 
when a person tears a muscle. Acute muscle damage is a sterile condition normally 
accompanied by inflammation (2, 122). Therefore it is an ideal model to address our 
scientific question. I have induced acute muscle damage by the injection of cardiotoxin 
(CTX). In the next section I will briefly describe the histological and immunological 
characteristics of this model. Moreover I will show the expression of Hmgbl during 
muscle repair to verify that the protein is expressed both by muscle myofibres and 
infiltrating leukocytes.
1. Characteristics of CTX-induced acute damage model
1.1 Kinetic o f repair o f CTX injected muscle
I have injected cardiotoxin (CTX) directly in tibialis anterior (TA) and 
quadriceps (Q) muscles bilaterally as depicted in figure 1.1 (panel A). I have then 
stained using hematoxylin and eosin (H&E) sections from TA muscles at distinct time 
points, as shown in figure 1.1 (panel B). At dayl after CTX injection a massive death of 
muscle fibers and few infiltrating cells are evidenced. At day3 mononuclear cell 
infiltration is substantially increased. At day5 infiltrating cells persist and some 
regenerating, centrally nucleated fibres appear. At day7 and day 10 infiltrating cells 
progressively disappear. The described regeneration is not substantially different 
depending on mice genetic background and recapitulates in a relative short time the 
homeostatic response of a tissue to a sterile injury. Thus this represents an ideal model 
to study the role of Hmgbl in tissue repair.
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Figure 1.1 -  Kinetic of the response of skeletal muscle to a sterile injury A. Cardiotoxin (CTX) 
is injected into tibialis anterior (TA) muscle as shown in the cartoon. B. Injured TA are retrieved and 
stained with H&E staining at various times (20x magnification). After CTX injection there is tissue 
necrosis in appearance (dayl); at later time points inflammatory leukocytes infiltrate the muscle. From 
day5 centrally nucleated, regenerating fibres appear. The full regenerative phase starts at day7; by daylO 
the inflammatory infiltrate is virtually disappeared. By day30 (not shown) the muscle is completely 
healed.
1.2 Immunological characterization o f CTX injected muscle 
To demonstrate that CTX injection does not affect the composition of peripheral 
blood of injected animals I have analyzed the peripheral blood by cytofluorimetric 
analysis (Figure 1.2). On the gate of CD45+ cells I have analyzed the expression of 
CD lib  for myeloid cells, F4/80 for monocyte/macrophage lineage, CD3 for T 
lymphocyte and CD 19 for B lymphocyte. The expression of CD lib  and F4/80 is 
virtually unchanged in CTX injected vs. healthy mice. There is a slight decrease in the 
percentage of CD3+ cells from dayl after CTX injection that however is not statistically 
significant. The percentage of CD19+ cells seems to be increased. However the basal 
percentage of CD19+ cells is already slightly higher in the CTX injected group. Also in
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this case the differences are not statistically significant. Also on a biological point of 
view a difference of 1-5% in the presence o f specific peripheral blood population is 
encompass in the normal variability that can be found from mouse to mouse.
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Figure 1.2 -  The injection of CTX does not perturb the general composition of peripheral blood. 3 
mice/group are injected either with CTX or vehicle. Tail vein bleeding is performed at the indicated time 
points and peripheral blood is analyzed by cytofluorimetric analysis. The graphs show the average of die 
percentage of the indicated marker on the total CD45+ population ± SD. t-test for unpaired data is applied 
at each time point.
Michela Vezzoli in the lab has shown that CD45+ cells, so bona fide  leukocytes, 
peak at day3 after CTX injection. The same kinetic has been described for 
macrophages, that thus are the predominant infiltrating population at early time points 
after CTX injection (75). Macrophages in CTX injected muscle display the typical 
scavenger phenotype of tissue-repairing macrophages. They express CD 163 since day3 
after damage but its expression is lost at later time points (day7 and 10). The expression 
of CD206 is instead stable and it persists all throughout the damage and repair process
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(42). Finally Lidia Bosurgi in the lab has confirmed the crucial role of macrophages in 
muscle repair after CTX injection (128), as already reported in a model of notexin 
injection (2).
The next step has been to verify whether and how Hmgbl is expressed.
1.3 Hmgbl expression during damage and repair after CTX injection
Immunofluorescence (IF) reveals Hmgbl expression (red) in TA sections before 
injury and at later times (day3 and day7). Nuclei are counterstained with Hoechst (blue). 
Hmgbl is normally expressed in some but not all nuclei (Figure 1.2, panel A, left 
picture). As expected Hmgbl expression in quiescent myofibres is mostly restricted in 
the subsarcoplasmatic muscle domain, where nuclei are located. A western blot analysis 
confirms that Hmgbl is present in healthy muscle, albeit at low levels (Figure 1.2, panel 
B, lane “0”). Hmgbl is released upon active tissue injury: at dayl after CTX injection 
there is a ten-fold increase in the serum concentration of Hmgbl, as reported in Figure
1.2 (panel D). Hmgbl levels abate at later times, when dead fibres disappear and 
regeneration takes over (day3 and day5). IF for HMGB1 at day3 and day7 indicates that 
mononuclear infiltrating cells also express Hmgbl (Fig. 1, panel A). The result is 
confirmed by western blot for Hmgbl on CD45+ leukocytes retrieved from 
damaged/regenerating muscles at distinct time points. Infiltrating leukocytes 
consistently express the protein at any time point analyzed.
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Figure 1.3 -  Local and systemic H m gbl expression in injured and regenerating muscles. A. 
Immunofluorescence for H m gbl before damage and at day3 and day7 after tissue dam age (top panels, red 
colour). Nuclei are counterstained with Hoechst 33348. Pictures shown are at 40x magnification. H&E 
staining o f tissue at the same time points are shown in the bottom panels. H m gbl expression is restricted 
to subsarcoplasmatic domain in healthy muscle (NT). It is also expressed by infiltrate (day3) and by 
central nuclei o f regenerating fibres (day7) B. W estern blot for mouse H m gbl on total m uscle lysates. 
Hm gbl is present in healthy muscle. H m gbl increases after acute damage and remains high till d a y l5. 
GAPDH is used as housekeeping protein. C . W estern blot for mouse H m gbl on CD 45+ leukocytes 
retrieved at distinct time points from damaged muscle by magnetic beads sorting. Infiltrating cells express 
H m gbl at any time point analyzed. Identical quantity o f  total protein is loaded on each lane D. H m gbl is
HMGB1
p-actin
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measured by ELISA on sera collected from damaged mice at distinct time point after CTX injection. At 
dayl there is the peak of circulating Hmgbl, together with the peak of muscle fibres death.
2. MRI as a tool to study acute muscle damage
An obvious limitation of the experiments described so far is the impossibility to 
non-invasively follow muscle response to injury in single mouse. To overcome this 
problem, I have focused on the establishment of a magnetic resonance imaging (MRI) 
approach to longitudinally obtain information on the muscle characteristics without the 
need of sacrificing animals at each time point.
2.1 Introduction to MRI
A non-invasive tool for quantitative and dynamic assessment of the skeletal muscle 
modifications during acute damage and regeneration would find several important 
preclinical and clinical applications.
Magnetic Resonance Diffusion Tensor Imaging (DTI) enables to describe the
skeletal muscle architecture investigating the differential diffusion of water in different
directions of space (129). Due to fibrillar structure of normal skeletal muscles, the
diffusion of water is greater along fibres orientation than in other directions o f space.
The diffusion of water on a specific direction is a physical property called anisotropy.
The anisotropic diffusion, characterizing the intact skeletal muscles, is easily quantified
by DTI, measuring the fractional anisotropy (FA) (130). In case of injuries affecting the
myofibres integrity, the anisotropic property of skeletal muscles is perturbed because of
loosing of a preferential direction of diffusion. Heemskerk et al demonstrated the
decrease of FA after an ischemic injury. They studied C57BL/6 mice before femoral
artery ligation and at distinct time points after surgery. They performed a comparison
between the modification of MR parameters and the qualitative visual assessment of
histological changes. The FA dropped after the ischemic injury and progressively
increased during the muscle regeneration (131), suggesting that FA could be an
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interesting parameter to monitor muscle damage and regeneration. The main limitation 
of this study is that the authors compared histology and magnetic resonance results only 
in a qualitative and not in a quantitative way. Moreover the FA values are 
mathematically derived from MRI sequence and not directly investigated, as I will show 
later in our study.
A commonly accepted MRI sign of muscle damage is an increased signal in T2- 
weighted images linked to T2 relaxation time (T2rt) lengthening. The increase in the 
T2rt values mirrors several phenomena, such as muscle oedema, inflammation and 
necrosis (132-134). T2rt could help to obtain valuable information in the follow-up of 
cardiotoxin-induced muscle injury mouse model. However only a very preliminary 
study without any direct histological comparison is currently available in literature. On 
ischemic muscular injury, the modification of T2rt occurring during muscle after 
damage have been assessed. T2rt was increases at day 3 after femoral artery ligation and 
is followed by a progressive normalization; however, any direct correlation is 
performed between the T2rt changes and the histological modifications.
Multiparametric MRI could therefore represent a very promising tool for 
quantitative monitoring the structural changes occurring after a muscle injury, however 
further data about the comparison between the MRI parameters and the histological 
changes in preclinical model of muscle damage were required when I started my PhD 
project. The following experiments are aimed at prospectively evaluating a 
multiparametric MRI protocol as a non-invasive and quantitative tool to assess muscle 
injury and to monitor muscle healing process, obtaining dynamic information about 
inflammatory infiltrate and fibres regeneration.
2.2 Analysis ofTA muscle by MRI
In figure 2.1, panel A a sagittal (sag), coronal (cor) and axial sections o f mouse
hind limb is shown. All images are T1 weighted. All analysis are performed on ten
slices with 1mm interslice distance (open red rectangles). The reference section
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analyzed is axial (dotted red line). By such an approach we simultaneously sample the 
whole muscle length, from the knee to the footpad. For each sequence, graphs show the 
average ± standard deviation o f 5 slices. Values are calculated on specific regions of 
interest (ROI). One ROI is placed on the TA muscle that will undergo damage. The 
control ROI is placed on the gastrocnemius (G), at the opposite side o f the leg.
Mice analyzed All m ice 3 3 3 3 3 3 3
Mice sacrified 2 3 3 3 3 3 3 3
Figure 2.1 -  Establishm ent o f  an MRI imaging approach to the study o f muscle dam age and 
repair in vivo. A . A coronal (cor), sagittal (sag) and axial section o f a healthy muscle leg. Red boxes 
highlight the area analyzed. Images shown here are from an anatomical T1 sequence to study the best 
positioning for the mouse into the instrument. B. Experim ental design to validate MRI as a valuable tool 
to follow muscle healing in vivo. Green arrows indicate the time points at which MRI is perform ed. 
Orange arrow indicates the tim e o f CTX injection. Coloured arrows indicate the tim e points at which 
mice are analyzed and sacrificed.
RM
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To validate quantitatively and qualitatively MRI as a tool to describe muscle 
injury and healing we have designed an ad hoc experiment in collaboration with the 
Radiology department (Figure 2.1, panel B). Sequences used are T2 map, diffusion 
tensor imaging (DTI) and diffusion map. In following subchapter each sequence is 
described and analyzed. The whole cohort of mice has been investigated before any 
injury (0) and 2 mice are sacrificed immediately to compare histology with MRI 
images. Mice are then injected with CTX and followed by 7T MRI at dayl, 3, 5, 7, 10, 
15 and 30 after muscle damage. At each time point 3 animals are sacrificed, TA isolated 
and frozen for subsequent histological analysis.
2.3 MRI as a tool to assess muscle oedema and inflammation
Oedema is visualized on T2 weighted MRI images as hyper intense (white) 
areas. T2 relaxation time (T2rt) value is related to the extent of the oedema: the higher 
the T2rt, the more extended the oedema. Oedema is expected to appear after tissue 
damage in the TA muscle (red line on graphs), but not in control muscle (G, green line 
on graphs) and is related to the inflammatory status of the tissue. The simultaneous 
assessment o f TA muscle histology (Figure 1.4, panel A, top line) and T2 weighted 
images (Figure 2.2, panel A, middle line) reveals a good association between high T2rt 
values and qualitative or semiquantitative results in H&E stained tissues (Figure 2.2 and 
nor shown). In the bottom line the T2rt profiles of one representative mouse per time 
point are shown. In figure 2.2 panel B I report the dynamic changes of T2rt at distinct 
time points after tissue damage. As expected the T2rt peaks between day3 and 5, at the 
top of the inflammatory response. Control muscle (G) is virtually unaffected by oedema 
in TA muscle.
In collaboration with Antonella Monno in the lab I have set up a score to 
evaluate the entity of infiltration in H&E sections. 0 corresponds to the absence of 
infiltration, while 5 correspond to the most infiltrated section. For each mouse 4 serial
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sections are evaluated and each dot in the graph represents the average o f 3 mice per 
time point. The histological score and the number of CD45+ cells (bona fide  
leukocytes) extracted from damaged muscles at each time point (Figure 1.4, panel C and 
D) have been significantly correlated with the T2rt, suggesting that this parameters 
reflects the overall extent of oedema and inflammation in the injured and regenerating 
tissue.
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Figure 2.2 - T2 map sequence can be used to follow muscle oedema. A. Qualitative com parison 
between MRI images (interm ediate line) and histological sections (H&E, 20x m agnification, top line) at 
distinct time points. In bottom line relaxation time plots are reported B. T2rt analysis is perform ed on TA 
(damaged, red line) and gastrocnem ius (G, control, green line). T2rt values are reported. 3 anim als are 
analyzed for each time point. Average ± SD is reported. Each time point is com pared with basal values 
for statistical analysis. One-way ANOVA is applied. * p<0.05 C. T2rt mean values at each tim e point are
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correlated with histological score, expressed as arbitrary units (a.u.). D. T2rt was correlated with the 
number of muscle infiltrating leukocytes, retrieved by immunomagnetic sorting. For both C and D 
correlation was evaluated using Person test. p<0.05 was considered as statistically significant.
2.4 MRI is a valuable tool to study tissue architecture during muscle damage
Muscle in physiological conditions is a bundle o f fibres oriented in the same 
direction. Water inside fibres is oriented in the same direction. Mechanical constrains 
thus restrict the kinetics of water molecules: accordingly, in an axial section of a mouse 
leg, the preferential direction of water is orthogonal. This pattern of movement is 
visualized by the blue colour in the images (Figure 2.3, panel A, time 0). When fibres 
are disrupted water randomly diffuses into the muscle. The black colour reflects the lack 
of preferential direction in the movement of water molecules (Figure 2.3, panel A, 1 and 
3 days after CTX injection). The reconstitution of the fibres corresponds to a 
predominant blue pattern in the DTI analysis. Variations in the Fractional Anisotropy 
(F.A., y axis, Figure 1.6, panel B and C) reflect these events. TA has in normal 
condition a F.A. = 0,3. After injury the F.A. value drops (dayl, F.A.=0,09). Values rise 
when regeneration starts (day5) and return to normal levels by day30. The control 
muscle (G) is in contrast virtually unaffected. We have counted the number of fibres in 
a given section and the number of regenerating fibres, identified based on the nuclear 
position (i.e. central in regenerating fibres, peripheral in resting fibres). F.A. values at 
day 3 (2 mice), day 5 (3 mice), day7 (3 mice) have been correlated with the number of 
centrally nucleated fibres/FOV as a surrogate marker of the extent o f muscle 
regeneration (Figure 2.3, panel C).
Diffusion constant parameter represents a further qualitative parameter to assess
2,tissue regeneration. It estimates the speed of water and is expressed in mm /sec. The
lower the diffusion constant, the higher is the cellular density of a tissue. Figure 2.3
panel D illustrates the dynamic changes of diffusion constant during muscle damage
and healing process. The speed of water increases after injury reflecting the loss of
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cellular density. The diffusion constant drops and returns to basal levels by day30, 
reflecting effective tissue healing.
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Figure 2.3 -  Fractional anisotropy and diffusion constant can be used to quantitatively assess 
and prospectically follow variations of the muscle architecture. A. Qualitative analysis of axial section 
with diffusion tensor imaging. Blue colour represents an orthogonal direction of water molecules. B. 
Quantitative analysis for water direction in damaged and repairing TA. On the x axis time is reported. On 
the y axis the fractional anisotropy (F.A.) values are indicated. For each time point we report the average 
± SD of three mice for F.A. For each mouse 5 slices are analyzed both on TA (red line) and G (green line) 
muscle. Each time point is compared with basal values for statistical analysis. One-way ANOVA is 
applied. * p<0.05 C. For each mouse the percentage of regenerating fibres is calculated and then 
correlated with the F.A. values at distinct time points (day3, day5, day7). Each dot represents a mouse. 
Correlation was evaluated using Person test. P<0.05 was considered as statistically significant D. On x 
axis there is time while on y axis is the value of diffusion constant. For each time point we report the 
average ± SD of three mice for diffusion constant. For each mouse 5 slices are analyzed both on TA (red 
line) and G (green line) muscle. Each time point is compared with basal values for statistical analysis. 
One-way ANOVA is applied. * p<0.05
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DISCUSSION - 1
The injection of CTX to induce muscle damage is an ideal model to study the 
immunological events underlying muscle repair. The kinetic of skeletal muscle repair is 
quick and in 7-10 days almost all fibres display a centrally-nucleated appearance typical 
of regenerating fibres. The decrease in the number and in the size of regenerating fibres 
is a quantitative parameter that can be assessed as a sign of aberrant repair. Since the 
aim of the study is to dissect the relative role of leukocyte Hmgbl respect to tissue 
Hmgbl the CTX injection should not perturb peripheral blood leukocyte composition. 
The analysis of monocyte, T and B lymphocyte on peripheral blood after CTX injection 
demonstrate that this is the case. The slight decrease, albeit not significant, of CD3+ T 
lymphocytes is consistent with a report in literature (135) that cardiotoxin-III is an 
inducer of activation-induced apoptosis o f human CD8+ T lymphocytes. Small amounts 
of cardiotoxin-III are present in our mixture of cardiotoxin and, moreover, only a 
fraction of circulating CD3+ T cells is constituted by CD8+ activated lymphocytes. 
Finally the fraction of CTX mixture that from the muscle reaches the systemic 
distribution is probably too low to induce a greater effect on T lymphocyte viability. B 
cell increase observed at day7 after CTX injection can be justified by the fact that a 
tissue damage with massive cell death is often accompanied by the rising of a self- 
limiting autoimmune reaction with the production of low-titer autoantibodies (136).
To define the CTX injection model as an ideal system to address my scientific 
question Hmgbl should be present both in muscle and in infiltrating leukocytes. Hmgbl 
is present in total muscle lysates from undamaged muscle. The immunofluorescence 
analysis showed that Hmgbl in healthy muscle is located preferentially in nuclei of 
myofibres and, possibly, of satellite cells. The systemic release of Hmgbl in 
correspondence of muscle necrosis at dayl is a further evidence that Hmgbl is passively 
released by dying muscle fibres, according to its role as an alarmin (1, 51, 54). CD45+ 
cells isolated from damaged muscles at distinct time points after CTX injection express
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Hmgbl at any time point analyzed, thus confirmed that the protein in our model is 
expressed also by inflammatory cells. Immunofluorescence analysis at day3 and 7 
showed some nuclei of mononucleated infiltrating cells that are negative for Hmgbl 
staining. Those cells could have already secreted Hmgbl upon activation by cytokines 
present in the microenvironment (60, 93).
After the choice of the appropriate acute damage model I needed to set up a non- 
invasive tool to follow muscle damage in vivo, since no tools were available at the 
beginning of the project. In collaboration with the Centre for Experimental Imaging and 
with the Radiology department of the institute I have performed a longitudinal study to 
compare histological and MRI findings in a qualitative and quantitative manner. The 
aim of the present study was to validate a multiparametric MRI protocol for the 
dynamic and quantitative monitoring of skeletal muscle damage and healing. As 
presented in the introduction, the dynamic of regeneration are known from histological 
studies. However, histology has several limitations both in patients and in preclinical 
models as tool to investigate muscle damage: (i) the excision of muscle samples is a 
further trauma that could lead to confounding results; (ii) biopsies allow to obtain only 
segmental information without a panoramic assessment; (iii) the mice has to be killed to 
collect muscles and investigate their architecture. A non-invasive tool for longitudinal 
monitoring of muscle regeneration would be fundamental help in basic research, as well 
as in the investigation of immunological aspects of several myopathies, including 
muscular dystrophies and autoimmune polymyositis. For our study we used the acute 
muscle damage model based on intra muscle CTX injection as it is useful to study both 
tissue and inflammatory dynamics. We monitored the changes of T2rt, speed o f water 
diffusion and FA at distinct time points after CTX injection and we performed 
correlations with data from quantitative analysis of histological samples.
In normal muscle the T2-rt is shorter than in other parenchymal tissues because of 
the strong contribution of the intracellular muscle compartment in which water T2 is
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very short. From a physical point of view, the T2rt modification observed are likely to 
be linked to muscle oedema. T2 rt is a parameter to follow muscle oedema after tissue 
damage. We investigated the possibility that, besides oedema, it could be a more 
general parameter to follow inflammation, both on its humoral and cellular component. 
T2rt proved to positively correlate with the number of infiltrating cells and the 
histological score based on the infiltration level and the morphological appearance of 
the muscle. Consistently with the results reported in literature the diffusion constant 
(speed of water inside the tissue) increases at day 1 after injury and suddenly was back 
at basal level at day 3 (134). As already suggested these modifications could reflect the 
changes in fibre size, especially because the diffusion of water measured in skeletal 
muscles largely reflects the diffusion in the intracellular space (134). Therefore, the 
myocytes swelling observed immediately after injury is likely to determine the diffusion 
constant increase at day 1. The mismatch between diffusion constant and T2rt results at 
day 1 and 3 after injury indicates that the two parameters reflect distinct processes, 
being the former related to muscle structure and the latter to muscle inflammation. The 
diffusivity at later time points (day 5 and 7) becomes lower than in untreated muscle. 
The phenomenon can be explained by the fact that fibre size of regenerating cells is 
inconstant and lower than healthy fibres (137). Even more interesting are the changes of 
FA. Albeit specular to the modification of diffusion constant, the FA changes are larger. 
The intact skeletal muscle is characterized by an anisotropic diffusion of water (FA ~
0.3), similarly to healthy white matter of the brain (138, 139). At day 1 the tissue 
integrity is disrupted and, as expected, we observe the loss of the skeletal muscle 
anisotropic feature. Between day 5 and 7 the FA shows a fast increase above basal 
levels. The increase can be explained by the appearance of regenerating fibres. In fact at 
day 5 and 7 the centrally nucleated fibres, albeit present, are still immature and with a 
reduced diameter. At the same time points histology unveils that muscles are M l of 
mononuclear infiltrating cells. Given that water diffusion is mainly intracellular and that
intercellular spaces are filled by inflammatory cells, it is easy to figure out an increase 
in FA. By day 30 histological sections show a progressive normalization of fiber 
diameter and a decrease in infiltration. Thus, as expected, water diffusion normalized as 
well. Based on these considerations, the FA changes seem to express the centrally 
nucleated fibers appearance and maturation. In conclusion, our study contributes to 
demonstrate that a multiparametric MRI protocol, including T2-mapping and DTI, 
could be considered an effective non invasive tool to obtain a panoramic monitoring of 
muscle damage and repairing process with a quantitative readout.
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RESULTS - 2
1. Hmgbl action in injured/regenerating muscle
In a first set of experiments I have used a pharmacological approach to study the 
contribution of extracellular Hmgbl to muscle damage.
1.1 Schedule for pharmacological blockade o f extracellular HMGB1 
In a first set of experiment I have injected the competitive antagonist for 
Hmgbl, BoxA, at the site of injury. BoxA is injected together with CTX into TA 
muscle and the treatment is repeated (Figure 1.1, panel A). Control muscles have 
received the vehicle with the same schedule (saline/BoxA green arrow, CTX-saline 
orange arrow). MRI is carried out as indicated by blue arrow. 6-7 mice are sacrificed at 
day7, 15, 30 (red arrow) and various aspects of muscle assessed. 3 animals are 
sacrificed at dayl and 3 only for muscle weight analysis. Each mouse receives saline on 
one leg and BoxA in the controlateral leg.
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Figure 1.1 -  Effects of Hmgbl in injured and regenerating muscle. A. Schedule of BoxA 
treatment. BoxA is injected in TA together with CTX. Blue arrow indicates MRI analysis, red arrow 
indicates sacrifice of mice. 7 animals are sacrificed at day7 and 14, 6 animals at day30 and 3 at dayl and 
3 for muscle weight analysis only. B. Muscle weight vs. time is graphed. Data from BoxA and sham 
treated mice are compared at each time point using a t-test for paired data. p<0.05 is considered as 
statistically significant (*). Red line represents BoxA treated muscles, green line represents sham treated 
muscles.
The weight o f treated TA muscles is significantly higher than sham treated 
counterparts at day 3 and 7. The difference is lost at day 15 and 30 and is not present at 
dayl (Figure 1.1, panel B and Figure 1.2).
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Figure 1.2 -  Hmgbl has an effect on muscle weight. A. B. C. Left histograms reports the 
comparison of each BoxA treated TA vs. sham treated controlateral TA. Right graph represents the 
comparison between the two groups of mice at day7. Non parametric analysis is applied. Associated p is 
indicated in the graph.
The aim of the project is to verify whether the leukocyte Hmgbl is involved in 
the control of muscle repair. Since extracellular Hmgbl is both of muscle and leukocyte 
origin, the first step is to verify whether the general blockade of extracellular Hmgbl 
brings to a defect in the inflammatory response following muscle injury or in the 
process of healing. After administration of BoxA we have qualitatively and 
quantitatively investigated the inflammatory response in injured and repairing muscle.
1.2 Hmgbl controls inflammation in muscle damage
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Weight assessment represents a rather crude approach, which possibly reflects 
tissue oedema and infiltration and possibly other events. In collaboration with the 
radiology department and Centre for Experimental Imaging of our institute I have thus 
used MRI to investigate and quantitatively detail the events occurring during the 
homeostatic response to muscle injury. I have analyzed oedema with T2 map sequence 
(Figure 1.3, panel A). T2rt are compared in sham and BoxA treated muscles. Oedema is 
slightly higher in BoxA treated mice at dayl and lower at day7, possibly reflecting a 
perturbation of the development of oedema in BoxA treated muscles. To assess the 
extent of inflammatory infiltrate I have analyzed by cytofluorimetric analysis the 
percentage of CD45+ cells after enzymatic digestion of muscles (Figure 3.3, panel B, 
left column). The same analysis is performed at dayl5 (Figure 3.3, panel B, right 
column). At both time points I have failed to detect significant difference between sham 
and BoxA treated muscles. Also the number of CD45+ cells is unchanged. This 
indicated that the difference in T2rt, albeit statistically significant, might be of limited 
biological relevance, since the extent of inflammation is comparable.
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Figure 1.3 -  H m gbl partially controls the size o f oedem a but not the num ber o f infiltrating cells.
A. On top panels qualitative analysis o f  T2 Map images is reported. We graphed T2rt values on y axis 
and time on x axis. For each time point we report the average ± SD o f  six mice. At each time point T2rt is 
compared between BoxA (red line) and sham (green line) treated TA. One-way ANOVA is applied. 
*p<0.05 B. The percentage o f CD45" cells (top graphs) and the num ber o f CD45+ cells (bottom  graphs) 
on total muscle cells is analyzed by flow cytometry at day7 and day 15 in sham (green bars) and BoxA 
(red bars) treated TA. t-test for unpaired data is applied. p<0.05 is considered as statistically significant. 
No differences are detected in flow cytometry analysis.
I have also assessed by flow cytometry whether the pharmacological blockade of 
H m gbl influences the distribution o f the various inflammatory populations, by
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selectively enhancing or dampening the recruitment of different cells. To this aim I have 
analyzed the expression of lineage markers, such as Ly6G (granulocytes), CD lib  
(myeloid cells), CD3 (T lymphocytes), CD 19 (B lymphocytes) and NK1.1 (NK cells). 
Hmgbl blockade by BoxA reduces macrophage infiltration at day7 (Figure 1.4, panel
A), while they are over represented at day 15 (Figure 1.5, panel A), possibly reflecting a 
delayed kinetics of macrophage attraction. T lymphocytes are reduced at dayl 5 (Figure 
1.5, panel B). The effect on macrophages and T lymphocytes is apparently specific 
since other leukocyte population are unaffected, such as B lymphocytes, NK and NK-T 
(NK1.1+-CD3+) (Figure 1.4 panel B, Figure 1.5 panel B).
Of interest, not only the kinetics of macrophage infiltration changes, but their 
functional polarization is also influenced, as verified at day 15 by the relative expression 
of receptors that tag pro-inflammatory (CD45+C D llb+F4/80+CD86+) vs. regenerative 
macrophages (CD45+C D llb+F4/80+CD163+) (Figure 1.5, panel A).
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Figure 1.4 -  Hmgbl influences the recruitment of macrophages at day7 after acute damage. A. 
The percentage of CD45+C D llb+F4/80+, CD45+C D llb+F4/80+CD86+ and CD45+C D llb+F4/80+CD163+ 
cells on total muscle cells is compared in sham vs. BoxA treated muscles. B. Cytofhiorimetric dot plot 
represent the percentage of CD45+CD3+ cells on total muscle cells. The percentages of CD45+CD3+, 
CD45+CD3XfKl.l+ and CD45+CD19+ are compared at day7 in sham vs. BoxA treated muscles. Both in 
A and in B green bars represent sham treated muscles, red bars represent BoxA treated mice and three 
mice per group are analyzed. Bars are average ± SD. *p<0,05.
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Figure 1.5 -  Hmgbl influences macrophage and lymphocyte recruitment in damaged muscle at 
dayl 5. A. The percentage of CD45+C D llb+F4/80+, CD45+CD1 lb+F4/80+CD86+ and 
CD45+C D llb+F4/80+CD163+ cells on total muscle cells is compared in sham vs. BoxA treated muscles.
B. Cytofluorimetric dot plot represent the percentage of CD45+CD3+ cells on total muscle cells. The 
percentages of CD45+CD3+, CD45+CD3+NK1.1+ and CD45+CD19+ are compared at day7 in sham vs. 
BoxA treated muscles. Both in A and in B green bars represent sham treated muscles, red bars represent 
BoxA treated mice and three mice per group are analyzed. Bars are average ± SD. *p<0,05.
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3.3 HMGB1 partially influences muscle healing
To investigate muscle architecture during damage and repair we use both 
histology and MRI. H&E staining is performed on TA treated or not with BoxA at 
day7,15 and 30 after muscle damage. Results are reported in Figure 3.6, panel A. there 
is a transient delay in tissue repair at dayl5, when some necrotic areas (blue spots) are 
still present in the tissue. However by day30 sham and BoxA treated TA have both 
repaired correctly. MRI analysis reveals that fractional anisotropy (F.A.) is higher in 
BoxA treated vs. sham treated TA.I Since macrophages influence muscle repair (2, 43, 
128) and results suggest that macrophage recruitment and polarization are at least 
partially dependent on extracellular Hmgbl, the following step has been to investigate 
whether the restoration of muscle architecture is impaired after BoxA treatment.IF A On 
the other hand F.A. is lower at day7 in BoxA vs. sham treated TA, while it is higher at 
day3, possibly reflecting a lower percentage of centrally nucleated fibres (Figure 1.6, 
panel B).
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Figure 1.6 -  H m gbl partially affects muscle repair. A. H&E staining is perform ed on sections 
from frozen samples. 3-6 mice per group per time point are investigated. Representative pictures for each 
group and for each time point are reported (20x m agnification). B . Diffusion tensor imaging is perform ed 
on six mice/group. On the x axis time is reported. On the y axis the fractional anisotropy (F.A.) values are 
indicated. For each tim e point we report the average ± SD o f three mice for F.A. For each mouse 5 slices 
are analyzed both on BoxA (red line) and sham (green line) muscle. A t each tim e point BoxA treated and 
sham treated muscles are compared for statistical analysis. Non parametric test is applied. * p<0.05
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Table 1 -  Sum up of results obtained with pharmacological blockade of Hmgbl. It has been highlighted 
that extracellular Hmgbl partially controls muscle healing at dayl5. Hmgbl controls oedema formation at 
day7 but not the number of infiltrating cells. It controls macrophage infiltration and partially macrophage 
phenotype. Hmgbl regulates T-lymphocyte attraction at day 15 while it does not impact on the infiltration 
of other cell population.
BoxA is a quick and dirty approach to study Hmgbl. It blocks both the Hmgbl 
that is passively released by dying fibres and the Hmgbl that is actively secreted by 
immune cells. The main goal of the present study is to elucidate why both the alarmin 
and the cytokine function of Hmgbl are needed for tissue repair. I have set up an ad hoc 
animal model to address this issue: a mouse that is Hmgbl proficient in all tissues and 
that lacks Hmgbl only in the haematopoietic tissue. To obtain such a mouse the most 
intuitive approach is to perform a bone marrow transplantation from Hmgbl7' mice into 
WT recipient. However Hmgbl7' pups die at pi because of severe hypoglycaemia and 
they are not suitable as sources for bone marrow transplantation. Foetal liver is the site 
of haematopoiesis in the intrauterine life. The peak of foetal haematopoiesis is at day 
E14.5.1 set up a model of foetal liver transfer to transplant Hmgbl7' precursors into 
lethally irradiated adult recipient.
In the next section I will present data about the set up of the foetal liver transplantation 
protocol. In this first part I have transferred WT foetal livers into WT recipients, to give 
the proof of principle that transplantation is working. In the last chapter of result I will 
show you the characterization of mice transplanted with Hmgbl7' vs. Hmgbl+/+ foetal 
livers.T, post-translational modification
2. Foetal liver transplanted mice have good chimerism in peripheral blood and in 
primary and secondary lymphoid organs 
To dissect the role of leukocyte and muscle Hmgbl we need a mouse model lacking 
one of the two sources of Hmgbl. We decided to generate a mouse model without 
Hmgbl in the haematopoietic system. The easiest way would be to transfer bone
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marrow from an Hmgbl'1' donor into an Hmgbl+I+ recipient. However, as mentioned in 
the introduction, Hmgbl'1' mice are not viable (115). Thus we have focused our strategy 
on generating a chimera starting from foetal liver, the anatomic site deputed to 
haemopoiesis in the foetus.
2.1 Chimerism assessment
I have first transferred WT foetal liver cells into WT recipients. To distinguish 
donor and recipient cells I have taken advantage of the CD45.1 and CD45.2 mismatch. 
Donor cells express the CD45.2, while recipient mice express the CD45.1 allelic 
variant. By cytofluorimetric analysis it is relatively easy to assess the percentage of 
donor and recipient cells in a given tissue.
I have analyzed the PB of 17 mice transplanted with 1:1 or 1:2 ratio 
donor:recipient ratio (Figure 2.1, panel A). Six weeks after transplantation the majority 
of circulating leukocytes is of donor origin. A negligible amount o f cells is of recipient 
origin (<10%). In the BM of 12 mice 10 weeks after transplantation (Figure 2.1, panel
B) the majority of leukocyte is of donor origin. A negligible amount of cells is of 
recipient origin (<1%). BM also contains a percentage of cells that are not of 
haematopoietic origin, possibly vessels or stromal cells. Virtually all C D llb+ cells are 
CD45.2+, i.e. o f donor origin (Figure 2.1, panel B, bottom right dot plot).
I have evaluated chimerism in secondary lymphoid organs, such as spleen 
(Figure 2.2, panel A), inguinal lymph nodes (LN, Figure 3.8, panel C) and in peritoneal 
liquid (Figure 2.2, panel B) 10 weeks after transplantation. The chimerism is 
consistently highly satisfactory with a negligible residual percentage of recipient cells 
(<5-10%). As expected the highest percentage of recipient cells is found in peritoneal 
liquid, probably because of the difficulty to erase the resident population with 
irradiation.
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Figure 2.1 -  A good chimerism is reached in peripheral blood and bone marrow of transplanted 
mice. A. Cytofluorimetric analysis of PB performed on 17 mice for the expression of CD45.1 and 
CD45.2. Alive cells are gated and doublets are excluded. On the alive, single cell population the analysis 
for CD45.1 and CD45.2 expression is performed. Qualitative appearance of dot plots is reported on the 
right. On the left there is the quantitative representation of results. In the histograms average ± SD is 
reported (n=17). B. Cytofluorimetric analysis of BM performed on 12 mice for the expression of CD45.1 
and CD45.2. Alive cells are gated and doublets are excluded. On the alive, single cell population the 
analysis for CD45.1, CD45.2 and CD l ib  expression is performed. Qualitative appearance of dot plots is 
reported on the right. On the left there is the quantitative representation of results for CD45.1 and CD45.2 
expression. In the histograms average ± SD is reported (n=12). For C D llb  expression one representative 
dot plot is reported on the right.
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Figure 2.2 -  Efficacy of foetal liver as a source of haematopoietic precursors. The fraction of
cells of donor (CD45.1+) and of recipient (CD45.2+) origin has been evaluated in the spleen (A. n=8),
peritoneal liquid (B. n=4) and inguinal lymph nodes (C. n=4).
2.2 Muscle regeneration after transplantation with foetal liver precursor cells 
Healthy TA has similar features in the two groups of mice, indicating that 
irradiation per se does not detectably perturb the tissue architecture (Figure 2.3, panel 
A). At day3 after injury the extent of necrosis and infiltration are similar. At day7 
regeneration simultaneously occurs in the two groups of mice. Transplanted mice have 
an apparently more sustained leukocyte infiltration even if  the difference is not 
significant. At day 10 the two groups of mice are comparable.
The greatest part of circulating cells is of donor origin. To be sure that donor and 
not recipient cells are preferentially recruited at the site of muscle damage I have 
stained for CD45.2 (marker of donor cells) muscle sections at day3 and day7 after 
injury (Figure 2.3, panel B).
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Figure 2.3 -  Cells o f  donor origin are effectively recruited at sites o f muscle injury. A. Injury is 
induced in 12 untreated (WT) or 12 transplanted animals (FLT). Representative pictures (20x 
magnification) are reported B. Muscle sections are stained for CD45.2 and CD68. Representative pictures 
o f one out o f three animals analyzed are shown (20x magnification) C. The percentage o f CD45.1+ cells 
is analyzed on CD1 lb + cells from damaged muscles. The analysis is perform ed on a transplanted animal 
(bottom dot plots) but also on a CD45.1 not transplanted mouse, as a positive control for CD45.1 
labelling.
The vast majority o f infiltrating leukocytes are CD45.2 . Moreover most of them 
express the CD68 marker. Results obtained with immunohistochemistry are confirmed 
physically retrieving leukocytes from the tissue and studying them by flow cytometry 
(Figure 2.3, panel C). The analysis reveals that in the gate o f C D l l t f  cells (bona fide 
macrophages) the greatest part o f the cells (around 90%) is CD45.2+, so o f donor origin,
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thus confirming that the procedure o f foetal liver transplant ensures good chimerism 
both in lymphoid organs and in inflamed muscles.
To better define the oedema in transplanted mice I have analyzed them using the 
MRI sequences introduce before. TA muscles o f injured mice transplanted or not with 
FL precursors have been analyzed using MRI before and at day3, 7 and 15 after 
damage. T2rt and F.A. are reported in Table 2. Transplantation does not influence T2rt 
trend in damaged TA. T2rt peaks at day3 after injury. At day7 the T2rt is still high; later 
on it declines as expected (see Table 2).
Untransplanted TA 16,16510,477 37,97710,606 31,103+1,972 25,401+3,721
Untransplanted G 15,79310,606 16,73010,536 15,49411,616 15,334+0,607
Transplanted TA 16,59410,724 39,50612,513 34,568+2,103 21,383+1,496
Transplanted G 16,49310,598 16,81410,310 15,86110,696 17,751+0,652
Table 2 -  Transplantation does not influence T2rt trend during muscle damage and repair. TA = tibialis 
anterior, G = gastrocnemius. n=3 at each time point, t-test for unpaired data is applied. No significant 
differences are detected between transplanted and untransplanted mice.
Foetal liver transplant does not impinge the kinetics of skeletal muscle response 
to sterile injury, as assessed by FA. During damage phase FA drops as expected (day3) 
and then promptly recovers (see Table 3) as it happens for untransplanted mice.
Untransplanted TA 0,306+0,008 0,20610,023 0,42110,02 0,37310,003
Untransplanted G 0,28010,011 0,29710,013 0,29410,014 0,25510,007
Transplanted TA 0,309+0,009 0,157+0,023 0,350+0,022 0,39110,003
Transplanted G 0,27510,013 0,287+0,013 0,29510,016 0,28210,003
Table 3 -  Transplantation does not influence F.A. trend during muscle damage and repair. TA =  tibialis 
anterior, G = gastrocnemius. n=3 at each time point. T-test for unpaired data is applied. No significant 
differences are detected between transplanted and untransplanted mice.
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3. Leukocyte Hmgbl controls muscle repair through regulation of angiogenesis
3.1 Effective chimerism in lethally irradiated WT mice transplanted with 
HmgbTA foetal liver cells (FLT)
Before analyzing muscle repair in transplanted mice it is necessary to verify 
whether transplantation procedure of Hmgbl'1' foetal livers ensures good chimerism at 
peripheral level. Figure 4.1 panel A demonstrates that transplanted Hmgbl"7' precursors 
effectively engraft, as assessed by the relative expression of CD45.1 and CD45.2 
markers. I have then verified the Hmgbl expression in circulating leukocytes by 
western blot analysis (Figure 3.1, panel B). A negligible amount of Hmgbl is indeed 
express, possibly reflecting residual recipient circulating leukocytes. Since no one 
before produced a model in which circulating white blood cells do not express Hmgbl 
we have further characterized our model by haemochrome analysis (Figure 3.1, panel
C). Hmgbl’1' FLT mice have fewer platelets and circulating leukocytes than their 
controls. The number o f red blood cells is unchanged in the two groups of mice.
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Figure 3.1 -  Hmgbl'7' FLT mice express negligible amount of Hmgbl in circulating leukocytes 
but have altered haemochromes. A. Chimerism analysis on WT FLT vs KO FLT mice. Cytofluorimetric 
analysis on peripheral blood (PB) of 7 mice/group (left panels). Residual host cells on PB have been 
identified as CD45.1+. B. Western blot analysis on WT FLT and KO FLT circulating white blood cells for 
HMGBl. P-actin has been used as loading control. C. Haemochrome analysis on PB of WT FLT (n=14) 
vs KO FLT (n=4) mice. The number of red blood cells (RBC, upper left panel), platelet (PLT, upper right 
panel) and white blood cells (WBC, bottom panel) have been evaluated. Data are analyzed by t-test for 
unpaired data. p<0,05 was considered as statistically significant (* = p<0.05, n.s. = not significant).
3.2 HmgbrA FLT mice have normal PB and BM  populations o f white blood cells
As mentioned in the introduction Hmgbl has several roles in controlling
immune responses (1, 51, 54, 81, 83). For this reason it is important to verify if,
together with a reduction in the number of circulating white blood cells, there is also an
impairment in the composition of leukocyte populations. I have analyzed by flow
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cytometry the composition of the CD45+population of both PB and BM 6 and 12 weeks 
after transplantation respectively (Figure 3.2). In panel A the comparison between a 
representative WT and KO FLT mouse is reported. WT and KO FLT mice do not differ 
in any of the population analyzed. The result is confirmed by the quantification 
performed on 4 independent mice (Figure 3.2, panel B). The same analysis is performed 
on BM. In the gate of CD45+ population several lineage markers are analyzed. No 
differences are seen between WT and KO FLT mice (Figure 3.2, panel C and D). These 
results highlight that, despite a lower number of circulating white blood cells, the 
composition of leukocytes is comparable between Hmgbl+I+ and Hmgbl'1' FLT mice.
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Figure 3.2 -  Hmgbl"7' FLT mice have normal leukocyte lineage distribution in PB and BM. A. 
PB cells from WT FLT and KO FLT mice are analyzed by flow cytometry (n=4). Representative dot 
plots from one Hmgbl KO FLT and one Hmgbl WT FLT mouse are reported. B. The percentage of 
lineage markers (Ly6G, CD llb, CD3, CD19, NK1.1) is calculated on CD45+ cells and reported in the 
colored histogram. C. Bone marrow cells from WT FLT and KO FLT mice are analyzed by flow 
cytometry (n=3). Representative dot plots from one Hmgbl KO FLT and one Hmgbl WT FLT mouse are 
shown. D. The percentage of lineage markers (Ly6G, C D llb, CD3, CD19, NK1.1) was calculated on 
CD45+ cells and reported in the colored histogram.
3.3 Leukocyte Hmgbl controls muscle repair
After the characterization of peripheral blood and bone marrow the next step has 
been to verify whether Hmgbl'1' FLT mice display alterations in muscle repair after 
acute damage. Thus it is possible to dissect the relative role of tissue and leukocyte 
derived Hmgbl in the context of sterile damage repair. Hmgbl'1' FLT mice and their 
controls are then damaged by CTX and repair is evaluated. At first we analyzed TA 
muscles by MRI. F.A. is analyzed at distinct time points (Figure 3.3). No differences 
between TA from WT and KO FLT mice are present, indicating a similar level of tissue 
necrosis at early time points and of myofibre regeneration at later time points. However 
this analysis does not give information about muscle morphology.
I analyzed by histology TA muscles from WT and KO FLT mice both at day7 
and day 15 after CTX injection (Figure 3.4 and Figure 3.5 respectively). H&E staining is 
performed. I have counted the number of centrally nucleated fibres at day7 and I have 
measured the diameters of regenerating fibres at day 15. The number of centrally 
nucleated fibres is lower at day7 in TA from Hmgbl KO FLT mice. Moreover at day7 
there is a greater fat presence in TA from KO FLT mice, as unveiled by RedOil 
staining.
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Figure 3.3 -  F.A. is not different in TA from WT and KO FLT mice. A. CTX dam aged tibialis 
anterior (TA) muscles from WT FLT and KO FLT mice are analyzed using MRI. Qualitative com parison 
between H m gbl WT FLT and H m gbl KO FLT mice at distinct time points is reported. B. Quantitative 
analysis o f  DTI sequence in the two groups o f  mice (n=7 in each group). F.A. is evaluated at distinct time 
points in five slices/mouse. One-way ANOVA is applied at each time point to compare TA from H m gbl 
WT FLT and H m gbl KO FLT mice. p<0.05 is considered statistically significant. No significant 
differences are detected.
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Figure 3.4 -  H m gbl is important for correct repair at day7. A. day7 CTX injected TA m uscles 
are displayed with hem atoxylin and eosin staining (H&E, A-upper panels) and the num ber o f  centrally 
nucleated fibers was counted (n=3, 10 successive slices for each mouse, B). On the same m uscle a Red 
Oil staining was perform ed (A - lower panels).
The measurement o f fibre diameter (cross sectional area, c.s.a.) at day 15 reveals that 
regenerating fibres in TA from KO FLT mice are dramatically smaller (Figure 3.5). 
This further support a role for leukocyte Hm gbl in guiding muscle repair.
103
A
WTFLT KOFLT
B C
p= 0,024
c.s.a. (nm2)
Figure 3.5 -  Leukocyte Hmgbl controls muscle repair at day 15. A. day 15 CTX treated muscles 
are analyzed by H&E (n=3 per group). Representative pictures from TA muscles at day 15 after CTX 
injection stained with H&E are reported B. Fiber diameter (cross sectional area, c.s.a.) is measured (left 
panel) in 10 serial section/mouse. 3 mice per group are analyzed. All data are compared using t-test for 
unpaired data. p< 0.05 was considered as statistically significant. *p<0.05 C. The result is visualized also 
by the comparison (right panel) between one representative mouse per group. C.s.a range are defined (x 
axis) and the number of fiber within a given range is reported (y axis).
Our data suggest that leukocyte Hmgbl controls muscle repair. The reason why 
leukocyte Hmgbl should control muscle repair remain elusive. Three main hypotheses 
can explain the phenotype observed:
1. Leukocyte Hmgbl controls inflammation, macrophage recruitment and/or 
macrophage polarization, known to be instrumental in repairing muscle 
(122)
2. Leukocyte Hmgbl controls satellite cell biology
3. Leukocyte Hmgbl controls angiogenesis in repairing muscle
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3.4 Leukocyte Hmgbl controls neither inflammation nor macrophage 
polarization
First I have defined whether Hmgbl is involved in the control of oedema during 
damage and repair process. Hmgbl WT and KO FLT mice are analyzed by MRI to 
investigate oedema in damaged TA muscle (Figure 3.6). Qualitative comparison 
between the two groups of mice reveals no apparent differences. Quantitative analysis 
of T2rt confirms that no difference in the extent of oedema is present. A slight, albeit 
not significant, increase in T2rt is detected at day5 and day7 in Hmgbl KO FLT mice, 
possibly unveiling a tendency to an increase in recruiting leukocytes at the site of 
damage.
KO FLTW TFLT
n=7
■c
P
time (days)
Figure 3.6 -  Leukocyte Hmgbl does not affect the extent of the oedema in damaged muscle. A.
CTX damaged TA muscles from WT FLT and KO FLT mice are analyzed using MRI (n=7 in each
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group). Qualitative comparison between Hmgbl WT FLT and Hmgbl KO FLT mice at distinct time 
points is reported B. From T2 Map sequence T2-rt is calculated in the two groups of mice at distinct time 
points. One-way ANOVA is applied at each time point to compare TA from Hmgbl WT FLT and 
Hmgbl KO FLT mice. p<0.05 is considered statistically significant. No significant differences are 
detected.
To better define how the infiltration is composed inside damaged and repairing 
muscles I have performed cytofluorimetric analysis. First I have verified chimerism at 
the site of damage. TA muscles from both WT and KO FLT mice at day7 after CTX 
injection are processed by enzymatic digestion. To verify chimerism in the tissue I have 
labelled digested muscles for both CD45.1 and CD45.2 (Figure 3.7, panel A). A 
minimal percentage of residual recipient cells is detected (<10% in both groups of 
animals), thus ensuring that the difference in the number of circulating white blood cells 
is not accompanied to an aberrant recruitment of leukocytes at the site of damage.
Since leukocytes such as macrophages are crucial for muscle repair (128), it is 
necessary to investigate if  the leukocyte populations that are present at the site of injury 
depend or not on their own Hmgbl for the recruitment. I have labelled cells from 
muscle digestion for CD45 together with several lineage markers such ad C D llb , CD3, 
CD 19 and NK1.1 (Figure 3.7, panel B and C). Ly6G is not used for the present analysis 
since granulocytes infiltrate muscle only till dayl after CTX injection. In particular in 
the gate of CD45+ cells I have analyzed the percentage of C D llb+ cells (bona fide  
macrophages, Figure 3.7 panel B). No differences are revealed, as confirmed also by the 
quantitative analysis performed on 3 mice/group. No differences are also present 
between all the other lineages analyzed comparing WT and KO FLT mice (Figure 3.7, 
panel C). Finally I have analyzed the expression of macrophage polarization markers on 
CD45+C D llb+ cells (Figure 3.7, panel D). I have used CD86 as marker for pro- 
inflammatory macrophages and CD 163 for anti-inflammatory macrophages. The 
cytofluorimetric analysis reveals no differences between the two groups o f mice for
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what concerns leukocyte infiltration. It seems that the percentage of C D llb+ cells is 
reduced. The slight reduction in CD1 lb+ cells is accompanied by a modest increase in 
the percentage of CD3+ and NK1.1+ cells. None of these differences are statistically 
significant and also the biological impact of such small variations is likely to be 
irrelevant. The big defects in muscle repair are seen when at least 50% of the total 
infiltrating macrophages is eliminated by the use of clodronate-lyposome approach 
(128).
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Figure 3.7 -  Leukocyte Hmgbl barely controls inflammatory cell recruitment at the site of 
damage at day7 after CTX injection. A. Total muscle cells after enzymatic digestion are analyzed by flow 
cytometry at day7 after CTX injection. CD45.1+ and CD45.2+ cell percentage is compared between the 
two groups of mice. B. C D llb+ cells percentage on total muscle cells is analyzed. Representative dot 
plots are shown. C. Infiltrate composition is analyzed in 3 mice/group. White bars represent Hmgbl WT 
FLT mice, black bars represent Hmgbl KO FLT mice. Data are compared using t-test for unpaired data.
p<0.05 is considered statistically significant. No differences are detected. D. The percentage of 
C D llb+CD163+ and the percentage of C D llb+CD86+ are analyzed on total muscle cells from muscle 
digestion in the two groups of mice at day7 after CTX damage.
For what concerns macrophage polarization the analysis unveils a difference in 
the percentage of CD45+C D llb+CD86+ cells. The difference is at the limit of statistical 
significance (p=0.06). However it could reflect a role for leukocyte Hmgbl in 
controlling, at least partially, macrophage polarization. It is interesting that the 
percentage of CD45+C D llb+CD163+ cells is unchanged. Some of the C D llb+ cells in 
Hmgbl WT FLT mice do not express nor CD 163 nor CD86. They could express other 
pro- or anti-inflammatory markers, such as CD80 or CD206 respectively. In the group 
of Hmgbl KO FLT mice the sum of CD45+C D llb+CD86+ and of 
CD45+C D llb+CD163+ cells is 100%. However it is not excluded that they could 
express other markers too. Collectively the results suggest that there could be a relevant 
increase in the proportion of macrophages with antigen presenting ability, a feature 
normally associated with pro-inflammatory macrophages. However the percentage of 
macrophages with scavenger (i.e. pro-healing) ability seems to be unchanged. To 
confirm a possible role of leukocyte Hmgbl in controlling macrophage polarization or 
at least antigen presenting molecule expression I have moved to an in vitro system. The 
difference highlighted in vivo is affected by the variability among animals. Moreover an 
analysis on cytokine expression will be performed on total muscle to verify whether the 
phenotypical change observed has functional consequences.
I have derived macrophages from bone marrow of transplanted animals. I have 
polarized in vitro both Hmgbl WT and KO macrophages. I have then analyzed their 
phenotypes by cytofluorimetric analysis and their cytokine secretions by ELISA. I have 
derived resting macrophages from BM of WT and KO FLT mice. Resting macrophages 
are then polarized using either IFNy to obtain pro-inflammatory (Ml-like) macrophages
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or IL10 to obtain anti-inflammatory (M2-like) macrophages (Figure 3.8, panel A and B 
respectively). WT and KO macrophages do not differ in their expression of several cell 
surface marker, such as lineage markers (C D llb, F4/80), antigen presenting and co­
stimulatory molecules (H2-kb, CD40, CD86) or scavenger molecules (CD 163, CD206). 
A decrease in MHC class II antigen (I-Ab) is unveiled. The difference is not statistically 
significant and points exactly in the opposite direction respect to the increase of CD86 
observed in vivo. The analysis of Hmgbl receptors RAGE and TLR4 is hampered by 
the lack of good antibodies for cytofluorimetric analysis. Taken together these results 
suggest that Hmgbl does not really shape macrophage polarization. It is more likely 
that it partially affects the antigen presentation ability of macrophages. This would be 
consistent with what is published in literature about the role of Hmgbl from dendritic 
cells in shaping activation and Thl polarization in CD4+ nai've T lymphocytes (94, 95). 
In any case this is unlikely to deeply affect muscle repair. The scavenger/regenerative 
ability of macrophage is likely to be the key feature of macrophages to mediate muscle 
repair (43, 122). However the scavenger receptor expression is unchanged both in vivo 
and in vitro.
To definitively rule out the possibility for Hmgbl to control macrophages 
polarization I have tested cytokine secretion in vitro by pro-inflammatory and tissue 
repairing macrophages. I have analyzed TNFa, typical of pro-inflammatory 
macrophages and IL10, typical of tissue repairing macrophages (8). Finally I have 
tested IGF-1, a molecule able to foster satellite cell proliferation and differentiation in 
regenerating muscle (140-142).
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Figure 3.8 -  Leukocyte Hmgbl does not control the expression of specific polarization cell 
surface marker of macrophages. A. Flow cytometry analysis of cell surface markers of WT vs KO pro- 
inflammatory macrophages (M l, n=3). B. Flow cytometry analysis of cell surface markers of WT vs KO 
anti-inflammatory macrophages (M2, n=3). A, B. Fluorescence is quantified using Relative Fluorescence 
Intensity (RFI, y axis). Results are analyzed by t-test for unpaired data and values p<0.05 are considered 
as statistically significant. No significant differences are detected.
Also ELIS As for TNFa, IL10 and IGF1 do not reveal differences between WT 
and KO derived macrophages, regardless of their polarization (Figure 3.9). This finding 
suggests that leukocyte Hmgbl is not involved in shaping macrophage polarization 
since at functional level there is not any difference in the secretion of cytokine.
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Figure 3.9 -  Leukocyte Hmgbl does not control the expression of cytokines specific for pro 
(Ml) or anti-inflammatory (M2) macrophage phenotypes. ELISAs are performed on conditioned 
supernatants from Ml and M2 macrophages, either WT or KO (n=3). Results are analyzed by t-test for 
unpaired data and values p<0.05 are considered as statistically significant. No significant differences are 
detected.
To further characterize inflammatory status of muscle I have sacrificed 3 
mice/group before CTX injection and at day 5, 10 and 15 after damage; I have then 
isolated mRNA from total muscle (TA) and performed real time RT-PCR. I have 
analyzed il6, tnfa and illO (Figure 3.10). In Hmgbl KO transplanted mice mRNA of 
il6, tnfa and illO fail to peak at early time points after tissue damage (day5). This could 
hyporeactivity of leukocytes in damaged muscle could be part of a bigger defect in the 
control of immune responses mediated by soluble factors. This issue would be better 
addressed in the paragraph 3.6.
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Figure 3.10 -  Leukocyte Hmgbl partially controls cytokine mRNA expression on total 
muscle. RT real time PCR on total muscle tissue for cytokines at distinct time points after muscle damage 
is performed. 116 (left panel), Tnfa (centre) and 1110 (right panel) were analyzed. Results are 
representative of one out of two series of animals.
Our data suggest that leukocyte Hmgbl does not control macrophage polarization 
in repairing muscle. Our data do not rule out the possibility that leukocyte Hmgbl is 
involved in modulating antigen presentation ability of macrophages. However leukocyte 
Hmgbl does not control the expression of scavenger receptors in vivo and in vitro, nor 
the secretion of cytokines by polarized macrophages in vitro. In vivo cytokines mRNA 
is modulated by leukocyte Hmgbl at early time points after tissue damage. At the 
beginning of the repair phase (day7) the gross composition of the infiltration is not 
depending on leukocyte Hmgbl. The analysis performed so far do not allow for a 
definitive conclusion about the functional activity of all infiltrating leukocytes. 
However the few differences revealed cannot account for the big healing defect 
observed in Hmgbl KO FLT mice. Thus I have further characterized the homeostatic 
response of WT and KO FLT mice to injury by analyzing muscle and satellite cell 
behaviour.
3.5 Leukocyte Hmgbl barely influences satellite cell biology
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I have analyzed the mRNA expression of some transcription factors related to 
myogenesis such as Pax7, MyoD, Myogenin and I have also analyzed the pro-myogenic 
factor Igf-1. The analysis is performed at distinct time points on total muscle mRNA. 
The expression of Pax7 and Igfl is lower at day5 and 15 in Hmgbl KO vs. WT 
transplanted mice. However at day7 we know from histology that the number of 
regenerating fibres is lower. Some of the factors analyzed, such as Igfl, are expressed 
both by inflammatory cells and muscle fibres. Thus it is not sufficient the qPCR 
analysis to establish whether the difference is a cause or an effect of the delayed repair.
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Figure 3.11 -  Leukocyte Hmgbl possibly controls the coming back to a quiescent state of satellite 
cells. A. RT real time PCR on total muscle tissue for transcription factors related to satellite cell function and
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myogenesis is performed. Pax7 expression level is shown in the upper left panel. MyoD is shown in the 
upper right panel. Myogenin is shown in lower left panel. Ig fl expression level is reported in the lower right 
panel. n=3 per group per time point. B. Immunofluorescence for Pax7 (green) and MyoD (red) is performed 
on frozen section from both WT FLT and KO FLT mice to verify satellite cell activation. At day7 and day 15 
the number of Pax7+ (arrowheads) and Pax7+MyoD+ (arrows) satellite cells is counted. Sections from 3 
mice/group per each time point are used for cell count (40x magnification). All results are analyzed by t-test 
for unpaired data and values p<0.05 are considered as statistically significant (* = p<0.05, n.s. = not 
significant).
To clarify this point I have stained frozen sections from WT FLT and KO FLT 
mice at day7 and 15 after CTX injection. The sections are stained for Pax7 and MyoD. I 
then count the number of Pax7+ or Pax7+MyoD+ cells. The number of quiescent or early 
activated, Pax7+ cells is not different in the two groups of mice at day7. At day 15 the 
number of quiescent cells is lower in Hmgbl KO transplanted mice. The number of 
activated, double positive cells is not different either at day7 and day 15. Our data 
collectively suggest that leukocyte Hmgbl is not involved in satellite cell activation at 
early time points. We cannot exclude that it controls the coming back to a quiescent 
state of activated satellite cells.
Differentiation is a key step in satellite cell biology. Macrophages have been 
demonstrated to deeply interact with satellite cells in this phase (44, 47, 143). To verify 
the role of leukocyte Hmgbl I have co-cultured pro- (Ml like) or anti-inflammatory 
(M2 like) macrophages with satellite cells in the presence or in the absence o f BoxA. 
Moreover I have repeated the same co-culture with both WT and KO derived 
macrophages. Finally I have differentiated satellite cells in the presence of conditioned 
supernatants from both WT and KO polarized macrophages. Positive controls are 
satellite cells in differentiation medium (DMEM+5% Horse Serum). Negative controls 
are satellite cells in growth medium (Ham FI0+20% Hyclone). Differentiation is 
quantified by counting the number of Myosin Heavy Chain (MyHC) positive myotubes 
with one nucleus, from 2 to 4 nuclei and with more than 5 nuclei.
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First I report that BoxA per se does not influence satellite cell differentiation 
(Figure 3.12, panel A). Also satellite cells express Hmgbl during proliferation and then 
down regulate it upon differentiation (Figure 3.12, panel B).
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Figure 3.12 -  BoxA does not impair satellite cells differentiation. A. Satellite cells are left in 
growth medium (20% Hyclone) as negative control. Satellite cells are differentiated in 5% Horse Serum 
(HS) for either 24h or 48h in the presence (right pictures) or in the absence (left pictures) of BoxA. In the 
Immunofluorescence blue is Hoechst 33342 (i.e. nuclei), green is MyHC (i.e. differentiated satellite 
cells). Quantitative results are reported in the histograms. White is the number of MyHC+ myotubes/field 
of view (FOV) with one nucleus. Grey is the number of MyHC+ myotubes/FOV with 2 to 4 nuclei. Black 
is the number of MyHC+ myotubes/FOV with 5 nuclei. Average ± SD of three independent experiments 
performed in double is reported. Results are compared using ANOVA. p<0.05 is considered statistically 
significant. No significant differences are detected B. Hmgbl expression in proliferating satellite cells 
(P), differentiating satellite cells (24h) and in differentiated satellite cells (48. Differentiating and 
differentiated satellite cells are analyzed in the presence or in the absence of BoxA. P-actin is used as 
housekeeping protein.
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Blocking Hmgbl with BoxA does not influence satellite cell differentiation, 
both if  co-cultured with pro- and anti-inflammatory macrophages (Figure 3.13).
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Figure 3.13 -  Extracellular Hmgbl does not control satellite cell differentiation. Co-culture is 
performed in permissive condition for satellite cell differentiation. Green = MyHC, red = C D llb  
(macrophages), blue = nuclei (20x magnification). Co-culture is performed in the presence or in the 
absence of BoxA using both Ml and M2 macrophages. Quantitative results are reported in the 
histograms. Grey is the number of MyHC+ myotubes/FOV with 2 to 4 nuclei. Dark grey is the number of 
MyHC+ myotubes/FOV with >5 nuclei. Average ± SD of six independent experiments performed in 
triplicate is reported. Results are compared using ANOVA. p<0.05 is considered statistically significant. 
No significant differences are detected.
The co-culture is repeated using pro- and anti-inflammatory macrophages both 
WT and KO derived. No differences are detected in any of the condition analyzed 
(Figure 3.14).
117
coc Ml coc M2 5% HS 20% Hyclone
WT
KO
I
14-i
I I2<x<4 nuclei 
1 I >5 nuclei 
n=3
2 -
0
5% HS 20% FBS wl KO wt KO
M1 M2
Figure 3.14 -  Macrophage Hmgbl does not influence satellite cell differentiation. Co-culture is 
performed in permissive condition for satellite cell differentiation. Green = MyHC, red = C D llb  
(macrophages), blue = nuclei (20x magnification). Quantitative results are reported in the histograms.
myotubes/FOV with >5 nuclei. Average ± SD of three independent experiments performed in triplicate is 
reported. Results are compared using ANOVA. p<0.05 is considered statistically significant. No 
significant differences are detected.
To definitively rule out the role of macrophage Hmgbl in the differentiation 
process of satellite cells I have grown the satellite cells in permissive condition for 
differentiation in the presence o f conditioned supernatants from both WT and KO pro- 
and anti-inflammatory macrophages. Data confirm that macrophage Hmgbl does not 
influence satellite cells differentiation (Figure 3.15). As a control satellite cells are 
differentiated in the presence of the cytokine used to polarize macrophages (i.e. IFN-y 
and IL10).
Grey is the number of MyHC+ myotubes/FOV with 2 to 4 nuclei. Dark grey is the number of MyHC+
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Figure 3.15 -  Macrophage Hmgbl does not influence satellite cell differentiation. Macrophage 
Hmgbl does not impair satellite cell differentiation. Satellite cells are plated in permissive condition for 
differentiation. Green = MyHC, blue = nuclei (20x magnification). Quantitative results are reported in the 
histograms. Grey is the number of MyHC+ myotubes/FOV with 2 to 4 nuclei. Dark grey is the number of 
MyHC+ myotubes/FOV with >5 nuclei. Average ± SD of five independent experiments performed in 
double is reported. Results are compared using ANOVA. p<0.05 is considered statistically significant. No 
significant differences are detected.
Collectively our data suggest that leukocyte Hmgbl does not control nor influence 
satellite cell activation and differentiation. We cannot exclude that Hmgbl play a role in 
controlling the step back to quiescence of activated satellite cells. However this is not 
sufficient to explain the dramatic phenotype we observe in muscle already at day7 after 
damage.
3.6 Leukocyte Hmgbl controls angiogenesis in repairing muscle
Up to now our results suggest that a modest influence of leukocyte Hmgbl on
inflammatory response is detectable. Leukocyte Hmgbl does not influence satellite
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cells activation during early phase of regeneration (day7). It could be of importance for 
the control of the coming back to quiescence of satellite cells. However these findings 
do not explain the dramatic phenotype observed. As mentioned in the introduction 
correct vascularization is instrumental to healing (6, 11, 16, 144). Hmgbl has been 
recently described as an angiogenic molecule (106-108). Thus I have analyzed the role 
of leukocyte Hmgbl in the control of vascularization after sterile damage.
To verify whether Hmgbl controls angiogenesis in repairing muscle I have 
stained day7 TA for CD31 (Figure 3.16, panel A). The number of vessels has been 
counted. The analysis reveals that Hmgbl KO FLT mice display a lower number of 
vessels respect to Hmgbl WT FLT mice, indicating a role for leukocyte Hmgbl in 
controlling vessel remodelling.
The question is how Hmgbl controls angiogenesis. I have verified whether 
leukocyte Hmgbl controls in a paracrine manner the expression of angiogenic factors in 
damaged muscle. I have analyzed mRNA expression on total muscle of Vegfp and 
Angiopoietin II (Angll) (Figure 3.16, panel B). Vegfp levels are similar in the two 
groups of mice. On the contrary Angll levels are dramatically reduced in Hmgbl KO 
FLT mice at day5. Our data suggest that leukocyte Hmgbl controls the transient up- 
regulation of Angll in early regenerative phase, necessary to allow new vessel sprouting 
(24). As a consequence at day 10 there are higher levels of Angll in KO FLT vs. WT 
FLT muscles. However the peak of Angll expression never reaches the expression 
levels observed in WT FLT muscles at day5.
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Figure 3.16 -  Leukocyte Hmgbl controls vessel remodelling in repairing muscle. A. Frozen 
sections from WT FLT (left panel) and KO FLT (right panel) TA at day7 after CTX damage are stained 
for CD31. Vessels are counted in at least 10 fields of view (FOV) at 20x magnification per mouse from 3 
mice/group and analyzed by t-test for unpaired data. p<0,05 is considered as statistically significant. 
(*p<0.05) B. Genes involved in angiogenesis are analyzed by RT real time PCR in WT FLT and KO FLT 
mice before damage and at distinct time points after CTX injection. Vegf/3 expression is shown in left 
panel, Angiopoietin II  expression is shown in right panel. Data are compared using t-test for unpaired 
data. p<0,05 is considered as statistically significant. (*p<0.05)
Thus leukocyte Hmgbl seems to control the correct kinetic and intensity of 
expression of Angll. The following question is how leukocyte Hmgbl controls Angll 
expression. Angll levels are controlled by hypoxia (24). Therefore I have measured 
H ifla  mRNA on total muscle at distinct time points (Figure 3.17). In damaged muscles 
from Hmgbl WT FLT mice H ifla  mRNA peaks at day5 after damage, while it is not 
upregulated in muscles from Hmgbl KO FLT mice. Consistently with the previous
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finding at day 10 in KOFLT muscles there is a persistence of H ifla  expression that 
however never reaches the peak of WT FLT muscle at day5. The present data suggest 
that leukocyte Hmgbl controls hypoxia sensing in damaged muscle. To further confirm 
this hypothesis I have measured mRNA levels of some H ifla  target genes, since H ifla  
is modulated at post-translational level. According to H ifla  expression defect at day5, 
mRNA levels of carbonic anidrase IX (CAIX) and of Glutl are dramatically reduced in 
Hmgbl KO FLT compared with Hmgbl WT FLT mice at day5. Our data support a role 
for leukocyte Hmgbl in vessel remodelling, possibly licensing damaged tissue to sense 
hypoxia thus driving angiogenic factor expression.
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Figure 3.17 -  Leukocyte Hmgbl licenses damaged muscle to sense hypoxia in early phase of tissue repair. 
C. H ifla  mRNA expression is evaluated on total muscle before damage and at distinct time points after CTX 
injection (upper panel). H IFla target genes are analyzed by RT real time PCR on the same samples. Glutl is 
reported in lower left panel and CalX is reported in lower right panel. Data were analyzed by t-test for unpaired 
data. p<0,05 was considered as statistically significant (* = p<0.05, n.s. = not significant).
Owing to the pleiotropic effects of Hmgbl (see INTRODUCTION) it has been so far 
unclear whether its role in wound healing depends on the Hmgbl derived from infiltrating 
leukocytes or from damaged tissues. My experimental model allows solving this issue. Its main 
feature is the possibility of recreating a chimeric situation in which damaged muscle are Hmgbl
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proficient and infiltrating leukocytes are either Hmgbl proficient or deficient. In the discussion 
hints on results interpretation and limits of the chimeric model are provided.
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DISCUSSION-2
In the present work we aimed at verifying a non-redundant role for leukocyte 
Hmgbl in muscle healing, a prototype of the healing process in sterile injuries. The 
combined pharmacological blockade and an animal model that I have established ad 
hoc, in which leukocytes selectively lack Hmgbl. The set up of the foetal liver 
transplantation procedure is first discussed here. When a chimera is generated the main 
issue to address is the chimerism. Chimerism on peripheral blood is satisfactory being 
routinely >90% of donor cells in the WT into WT setting. White blood cells are 
generated in the bone marrow (145). The chimerism in the bone marrow is even higher 
than in peripheral blood being routinely >95%. I have also demonstrated that the total of 
the bone marrow myeloid population is of donor origin. The population of CD45’ cells 
revealed in the bone marrow is likely to be composed by stromal and endothelial cells. 
In the spleen, lymph nodes and peritoneal liquid the chimerism is satisfactory as well. 
The population of CD45" cells in the spleen is possibly composed by stromal cells and 
red blood cells. It is intriguing to see a small percentage of cells that express both 
CD45.1 and CD45.2 markers. A fascinating hypothesis suggests that they are viable 
cells that have eaten dead counterparts and then they present on the surface the antigens 
of the dead counterparts (146, 147). In other words a viable CD45.2+ cells could have 
eaten a dead CD45.1+ cell and then it could have presented through MHC class I or 
class II molecule a fragment of the CD45.1 antigen, that is the epitope recognised by the 
antibody. Other explanation can be simply that the double positive cells are doublets 
that for some reasons elude the negative selection of doublets during acquisition of data, 
thus being merely the result of a technical bias. Another issue is the chimerism at 
muscle level after CTX injection. Residual host cells could have a selective advantage 
over donor cells and be preferentially recruited at the site of damage. Around 90% of 
infiltrating macrophages (C D llb+ cells) is of donor origin, thus excluding this 
possibility. Finally the muscle of irradiated and transplanted mice heals with a kinetic
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similar to untransplanted mice. This is confirmed both by histology and MRL It seems 
that a slightly higher infiltrate is present at day3 and 7, probably as a consequence of the 
irradiation procedure that per se elicits inflammation. This can be seen both by 
histology and by MRI analysis. However the increase of inflammatory cells is minimal 
and does not hamper muscle repair.
The satisfactory results in the WT into WT setting do not imply an equal 
efficacy when Hmgbl'7' foetal liver cells are transplanted. Another member of the High 
Mobility Group superfamily of protein, Hmgb3, has been shown to be crucial in the 
balance between self-renewal and differentiation in haematopoiesis (148). It is not 
excluded that Hmgbl could play a similar role. The chimerism on peripheral blood is 
good also in Hmgbl-/- FLT mice, being routinely >85% donor. However a higher 
percentage of residual host cells is detected. This result seems to indicate that Hmgbl'7' 
foetal liver cells have a lower ability to engraft. Haemochrome analysis reveals that 
erythropoiesis is conserved in Hmgbl'7' FLT mice. On the contrary platelet and white 
blood cells generation is impaired, since a lower number is detected. Since the number 
of white blood cells is reduced, the higher percentage of host cells results in a lower 
number of circulating host cells. In conclusion the chimerism is satisfactory and the 
number of circulating residual host cell is negligible. This is also confirmed by the fact 
that Hmgbl in circulating white blood cells of Hmgbl'7' FLT mice is barely detectable. 
However the impaired generation of white blood cells opens a question about the 
composition of peripheral blood and bone marrow. Are all the populations equally 
represented in the two groups of mice? The analysis by flow cytometry unveils no 
differences. Hmgb3 deficiency is supposed to enlarge the production of precursors at 
the expenses of more mature cells. It is conceivable that Hmgbl plays a similar role in 
managing the balance between precursors and mature cells. This remains just a 
speculation, since I have not analyzed precursors.
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Keeping in mind the possible limitation coming from an aberrant number of 
circulating white blood cells I have analyzed the chimerism at muscle level after CTX 
damage. The chimerism analysis confirms that the chimerism is satisfactory both in 
Hmgbl+/+ FLT and Hmgbl'7" FLT mice. Thus I continued analyzing the outcome of 
muscle repair in Hmgbl'7' FLT but also in mice treated intramuscularly (i.m.) with 
BoxA. Analyzing in parallel Hmgbl'7' FLT mice and mice treated with BoxA i.m. gives 
the possibility to dissect the role of extracellular Hmgbl respect to leukocyte Hmgbl.
Through in vivo imaging and cytofluorimetric analysis we are able to 
demonstrate that the pharmacological block of extracellular Hmgbl results in an 
impairment in the recruitment of inflammatory leukocytes. Interestingly, in our model 
in which leukocytes do not express Hmgbl these results are not replicated suggesting 
that muscle (extracellular) Hmgbl is primarily controlling leukocyte attraction.
Mice lacking leukocyte Hmgbl have an impaired, but not absent, muscle 
healing. The healing defect points to a non-redundant role for leukocyte Hmgbl in 
muscle repair, distinct from the role of total extracellular Hmgbl. In mice treated with 
BoxA the defect is limited to day 15, when some residual necrotic fibers are revealed by 
histological analysis. However the defect is rapidly recovered and it is not as dramatic 
as in Hmgbl KO FLT mice. The aberrant healing in this group of mice possibly 
involves a defective activation or differentiation of muscle stem cells. This does not 
seem to be the case: both in vitro and in vivo leukocyte Hmgbl does not influence 
satellite cell differentiation and activation. Leukocyte Hmgbl can be involved in the 
ability of satellite cells to replenish the quiescent satellite cell pool: TA from Hmgbl 
KO transplanted mice show a lower number of quiescent satellite cells. This is 
consistent with a recent report about the role of Hmgbl-RAGE axis in satellite cell 
quiescence (113). Quiescent satellite cell pool replenishment apparently does not justify 
the impaired muscle regeneration. Expression of myogenesis-related genes in muscles 
from Hmgbl KO transplanted mice is a consequence of the healing impairment rather
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than a cause of the impairment itself. Leukocyte Hmgbl results in a more effective 
regeneration, which is in turn dependent on the activation, proliferation and 
differentiation of satellite cells. When these events are jeopardized, such as in muscles 
from Hmgbl KO transplanted mice, expression of myogenesis related genes abates. As 
a result of a compensation effort of muscle to regenerate all myogenesis related genes 
experience a late peak of expression at day 10 after CTX injection. Given the dramatic 
healing defect observed at day 15 this compensatory reaction proves to be largely 
inefficient. It is possible that leukocyte Hmgbl is crucial in orchestrating early events in 
the repair process. In the absence of these early events the healing of the tissue is 
compromised. The lack of expression of myogenic genes in Hmgbl KO FLT mice may 
be a result of an overall decreased gene expression due to defective regeneration or a 
cause of the defect observed. The observation that at early times after injury the protein 
expression of myogenic factors such as Pax7 and MyoD is normal partially confirms the 
hypothesis of an overall reduced gene expression due to reduced myogenesis.
Leukocyte Hmgbl controls angiogenesis in regenerating muscle: this is 
demonstrated by the lower number of vessels in muscles from Hmgbl KO transplanted 
mice. In physiological condition muscle repair depends on vascularization (48). We 
have thus monitored the expression of angiogenic signals such as Vegfp and Ang2. 
Vegf]3 is present at normal levels in mice lacking leukocyte Hmgbl at any time point 
analyzed. In contrast Ang2 is dramatically reduced. Ang2 regulation is strictly required 
for vessel remodelling (24).
Collectively these data suggest that leukocyte Other signals, such as IL6 and 
TNFa may be also involved (16). Leukocyte Hmgbl controls the expression of il6 and 
tnfa mRNA. The defect in il6 and tnfa mRNA production in Hmgbl KO FLT mice can 
in part control angiogenesis even if  macrophages secrete the protein in the absence of 
Hmgbl when stimulated in vitro.
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This does not necessarily reflect what happens in vivo. Macrophages in vitro are 
cultured at an oxygen partial pressure similar to room air. In the tissue, macrophages are 
found into a lower oxygen partial pressure (6, 18). It is well known that inflammatory 
reaction and O2 tension are related (16, 24, 149). It has been proposed that damaged 
cells express and secrete molecules which modify key features of the extracellular 
environment, such as oxidoreductases and redox modifiers: in turn this signals cause 
structural and functional alterations in crucial pathways that mediate the cell response to 
environmental cues (150). Hypoxia is a major stimulus for the production of angiogenic 
factors such as Ang2, Tnfa and possibly IL6 (6, 16, 21). Hypoxia sensing in vivo passes 
mainly through H IFla (6, 24). Leukocyte Hmgbl is instrumental for the transcription 
of H ifla. HIFla activity is mainly controlled at post-translational level (6, 18). To 
verify whether H IFla activity is also reduced we monitored the transcript of H ifla  
target genes, such as carbonic anidrase 9 (CAIX) and the glucose transporter Glutl. The 
observation that both of them are reduced further strength the hypothesis that leukocyte 
Hmgbl controls hypoxia sensing in regenerating muscle.
Besides CAIX and Glutl the activation of other genes has been shown to depend 
on H ifla. This is the case of VEGFp (144). However I have failed to observe an effect 
of leukocyte Hmgbl on VEGFp production, suggesting that a hypoxia-independent 
pathway is involved, such as the EGFR/PI3K pathway recently proposed to be involved 
in VEGFP secretion by tumour cells (151). Both endothelial cells and alternatively 
activated macrophages produce high amounts o f VEGFP (7). Previous data in the 
laboratory demonstrate that macrophages infiltrating the injured and regenerating 
muscle display an alternatively activated phenotype (42). They could be responsible for 
a hypoxia-independent VEGFP production, which could involve the response to locally 
generated IL10. It has been recently described that stimulating monocytes with cancer 
cell supernatants containing IL10 results in monocyte production of pro-angiogenic
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factor such as VEGF and bFGF in a hypoxia-independent manner (152). Further 
experiments would be required to confirm this hypothesis.
Collectively our data suggest that leukocyte Hmgbl licenses damaged tissues to 
sense hypoxia. The hypoxia sensing allows the production of several angiogenic factors. 
The production of those factors mediates vessel remodelling, angiogenesis and 
ultimately effective healing (see cartoon below).
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A model for angiogenesis regulation by leukocyte Hm gbl in damaged tissues. During 
inflammatory response following damage hypoxia in a hallmark of the injured, inflamed tissues. 
Leukocyte Hmgbl licenses the tissue to sense hypoxia. Hypoxia sensing prompts the production of 
angiogenic molecules (TNFa, IL6 and Ang2). The balance among these factors leads to reconstitution of 
the vascular bed and ultimately to tissue healing.
Our model may apply also to other flsiopathological conditions in which 
vascularization is jeopardized. This could apply to solid neoplasms in which H IFla  
controls Ang2 expression (6, 18, 21). Generally the mechanisms underlying the 
regulation of HIFla/Ang2 expression are poorly understood. It is tempting to further
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investigate the role of leukocyte Hmgbl in controlling hypoxia sensing and 
angiogenesis in damaged tissues.
In this model many points need further clarification. First it is not clear how 
leukocyte Hmgbl could influence hypoxia sensing. It could be a direct effect of the 
secreted protein on neighbouring endothelial and muscle cells. It could be also an 
indirect effect: Hmgbl is a nuclear factor deeply involved in transcriptional control. It 
could mediate the expression of one or more factors by leukocytes and the unknown 
factors are the responsible for the hypoxia sensing effect. It is also not clear how 
Hmgbl control antigen presentation. I have evidenced some defects in the expression of 
molecules involved in this process that is of pivotal importance for the activation of 
adaptive responses, important as well to determine the correct reaction to tissue damage. 
The development of adaptive response needs further clarification and functional 
experiments to be substantiated. For example it would be interesting to perform an 
antigen presentation assay using dendritic cells and macrophages either Hmgbl WT or 
KO and WT or KO syngeneic splenocytes. Another key point is whether the effect is 
directly on endothelial cell by enhancing their sprouting ability or whether leukocyte 
Hmgbl controls the recruitment and the proliferation of pericytes and of endothelial 
precursors cells (79). Very recently a new mouse model that allows tracking of 
pericytes is available in the lab. It would be interesting to perform transplantation of 
Hmgbl KO precursors in this model and then to verify the contribution to regeneration 
of pericytes.
In conclusion my animal model allows showing for the first time that leukocyte 
Hmgbl controls muscle regeneration and possibly satellite cell turnover in damaged 
muscle. The control of muscle regeneration is likely to be mediated through the control 
of the vascularization of regenerating muscle. Our major hypothesis that needs to be 
further demonstrated states that leukocyte Hmgbl controls muscle repair through the 
control of vascularization that is achieved by controlling hypoxia sensing at early
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phases of healing. The main limitation of this study is the use of the chimera where a 
percentage, albeit negligible, of residual host cells is always present and could dilute 
some of the effects observed. Another limitation is the difficulty to mimic in vitro the 
complex relationship muscle-endothelium-leukocyte in order to dissect molecular 
events underlying this relationship. The main strength of the system is the unique 
opportunity to dissect the relative role of leukocyte and tissue Hmgbl, since up to now 
no animal model lacking only one of the two sources of Hmgbl were present. It would 
be of importance to dissect the relative role of the two Hmgbl also in other settings than 
muscle damage such as tumours or ischemic damage, where it has been demonstrated a 
general role for Hmgbl but without dissecting the molecular basis of this event (103, 
106, 124, 153, 154). That would be not only a biological speculation but would help in 
setting up therapies targeted to the dangerous component of the Hmgbl response but 
sparing the useful one. For example in tumours it would be of importance to spare a 
possible role in antigen presentation and T cell activation while eliminating an 
angiogenic response useful for tumour growth.
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